| |
1'-hydroxymidazolam
|
| |
1,3-butadiene sensitivity
|
| |
1-hydroxypyrene glucuronide, urinary
|
| |
1-hydroxypyrene, urinary
|
| |
1-hydroxypyrene, urinary levels
|
| |
2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine
|
| |
2-naphthol, urinary
|
| |
2-naphtol
|
| |
21-hydroxylase deficiency
|
| |
4'-hydroxymephenytoin
|
| | 5-fluorouracil- related toxicity
( see antineoplastic and immunosuppressive toxicity )
|
| | 5-flurouracil toxicity
( see antineoplastic and immunosuppressive toxicity )
|
| |
9-hydroxyrisperidone
|
| |
| | A |  Top |
| |
abacavir hypersensitivity
|
| |
abdominal aortic aneurysm
|
|
| |
Abeta load
|
| |
Abeta load in brain
|
| |
abruptio placentae
|
|
| |
absence of vas deferens, congenital
|
|
| |
ABT-773 plasma levels
|
| |
ACE activity
|
| |
ACE levels
|
| |
acenocoumarol pharmacokinetics
|
| |
acenocoumarol response
|
| |
acenocoumarol, sensitivity
|
| |
acetylcholine responsiveness
|
| | Achondroplasia
( see chondrodystrophy )
|
| |
acidosis
|
|
| |
acrocephalosyndactyly
|
| | acrocephalosyndactyly, type V
( see acrocephalosyndactyly )
|
| | acrylonitrile metabolism/toxicity
( see acrylonitrile toxicity )
|
| |
acrylonitrile toxicity
|
| |
acrylonitrile, metabolism
|
| |
ACTH
|
| |
ACTH, rate of decrease
|
| |
ACTH, rate of increase
|
| | actinic prurigo
( see solar radiation dermatitis )
|
| |
activated protein C resistance
|
| |
acute coronary syndrome
|
|
| | acute fatty liver of pregnancy
( see liver disorders in pregnancy )
|
| | acute Lymphoid leukemia
( see leukemia, lymphoid )
|
| | acute myeloblastic leukemia
( see leukemia, myeloid )
|
| |
acute respiratory distress syndrome
|
|
| |
adaptability trait
|
| |
Addison's disease
|
|
| | adenocarcinoma in colon polyps
( see colon polyps )
|
| | adenocarcinoma in polyps
( see colon cancer )
|
| |
adenocarcinoma of the small intestine
|
| | adenomatous polyps
( see colon polyps )
|
| | adenomyosis
( see endometriosis )
|
| | adipocyte size, large subcutaneous abdominal
( see obesity, localized )
|
| |
adiponectin
|
| | adiposity
( see obesity )
|
| |
adrenal anomalies, congenital
|
| |
adrenal hyperplasia, congenital
|
|
| |
adrenaline
|
| |
adrenocorticotropin
|
| | Adrenomyeloneuropathy
( see Addison's disease )
|
| |
adverse effects of anti-Parkinson agents
|
| |
adverse effects of sympatholytics
|
| | AFB1-albumin adducts
( see liver cancer )
|
| |
affective disorder
|
|
| |
affective psychoses
|
|
| | Agammaglobulinemia
( see agammaglobulinemia )
|
|
| | aggression
( see aggressive behavior )
|
| |
aggressive behavior
|
|
| |
agranulocytosis
|
|
| |
agreeableness
|
| |
airways hyperresponsiveness
|
| | Alagille syndrome
( see congenital malformation syndromes, other )
|
| | Albright hereditary osteodystrophy
( see chondrocalcinosis )
|
| |
albumin
|
| |
albumin excretion rate
|
| |
albuminuria
|
|
| |
alcohol abuse
|
|
| | alcohol associated symptoms
( see alcoholism )
|
| | alcohol consumption
( see alcohol abuse )
|
| | alcohol dependence
( see alcoholism )
|
| | alcohol drinking behavior
( see alcohol abuse )
|
| |
alcohol elimination
|
| |
alcohol withdrawal
|
|
| | alcohol, response to
( see alcoholism )
|
| | alcohol-induced testicular atrophy
( see alcoholism )
|
| | alcoholic brain atrophy
( see alcoholism )
|
| | alcoholic liver disease
( see liver disease, alcoholic )
|
| | alcoholic psychosis
( see psychosis, alcoholic )
|
| |
alcoholism
|
|
| | alcoholism with conduct disorder
( see psychosis, alcoholic )
|
| | ALDH activity
( see liver disorder )
|
| |
aldosterone
|
| | Alexander Disease
( see leukodystrophy )
|
| | allergic disease
( see allergies )
|
| | allergic disease, IgE mediated
( see allergies )
|
| | allergic diseases
( see allergies )
|
| |
allergic rhinitis
|
|
| |
allergies
|
|
| | allergy
( see allergies )
|
| |
allergy, food
|
| | allergy, latex
( see allergies )
|
| | allograft dysfunction, renal
( see kidney transplant complications )
|
| |
allograft outcome
|
| | allograft rejection after heart transplantation
( see heart transplant complications )
|
| | allograft rejection, heart
( see heart transplant complications )
|
| |
alopecia areata
|
|
| | alopecia, androgenetic
( see baldness )
|
| | Alpha mannosidosis
( see carbohydrate metabolism disorders, other )
|
| | alpha(1) antitrypsin deficiency
( see enzyme deficiency )
|
| |
alpha-carotene
|
| |
alpha-tocopherol
|
| |
alpha2-macroglobulin
|
| | Alport syndrome
( see congenital malformation syndromes, other )
|
| |
alprazolam metabolism
|
| |
ALS/amyotrophic lateral sclerosis
|
|
| |
altitude adaptation
|
| |
Alzheimer's disease
|
|
| | Alzheimer's disease related depression
( see Alzheimer's disease )
|
| |
amino acid disorder
|
|
| | aminoaciduria
( see amino acid disorder )
|
| | aminoglycoside ototoxicity
( see antibiotic toxicity, other )
|
| | amish lethal microcephaly
( see congenital malformation syndromes, other )
|
| |
amitriptyline
|
| |
amitriptyline metabolism
|
| | amyloidosis
( see Familial Mediterranean Fever )
|
| | amyotrophic lateral sclerosis
( see ALS/amyotrophic lateral sclerosis )
|
| |
analgesia response
|
| | anaphylactoid purpura
( see purpura, allergic )
|
| | anaphylaxis, food-related
( see allergy, food )
|
| | anaplastic astrocytoma
( see brain cancer )
|
| |
androgen
|
| | Androgen Insensitivity Syndrome
( see testicular dysfunction, other )
|
| |
androgen levels
|
| | androgenetic alopecia
( see baldness )
|
| |
androstenedione
|
| |
androsterone
|
| |
anemia
|
|
| |
anemia in pregnancy
|
|
| | anemia, acquired aplastic
( see aplastic anemia, acquired )
|
| |
anemia, aplastic
|
|
| |
anemia, iron deficiency
|
|
| | anemia, malaria related
( see anemia )
|
| |
anemia, megaloblastic, other
|
| |
anencephaly
|
|
| | aneurysm, abdominal aortic
( see abdominal aortic aneurysm )
|
| | aneurysm, intracranial
( see brain aneurysm )
|
| | aneurysm, subarachnoid
( see brain aneurysm )
|
| | Angelman Syndrome
( see congenital malformation syndromes, other )
|
| |
anger-related traits
|
| | angiitis, cutaneous leukocytoclastic
( see angiitis, hypersensitivity )
|
| |
angiitis, hypersensitivity
|
| |
angina
|
|
| |
angina of effort, stable
|
|
| |
angina pectoris
|
| |
angina, vasospastic
|
| |
angiodema
|
| | angioedema
( see enzyme deficiency )
|
| |
angiomyolipomas, renal
|
|
| |
angiopathy, diabetic
|
|
| |
angiotensin converting enzyme
|
| |
angiotensinogen
|
| |
ankylosing spondylitis
|
|
| |
anorexia nervosa
|
|
| |
anterior pituitary disorders, other
|
| |
anthropometric measurements
|
| |
anti-5-HMdU aAbs
|
| |
anti-p53 antibody expression
|
| |
antibiotic toxicity, other
|
| |
antibodies to 60 kDa heat shock proteins
|
| |
anticoagulant complications
|
|
| |
antidepressant adverse effects
|
| |
antidepressant response
|
| | antiemetic treatment outcome
( see nausea and vomiting )
|
| |
antilipemic toxicity
|
| |
antineoplastic and immunosuppressive toxicity
|
| |
antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis
|
| |
antioxidant activity
|
| |
antioxidant protection
|
| |
antioxidant status
|
| |
antiphospholipid syndrome
|
|
| |
antipsychotic weight gain
|
| | antisocial behavior
( see antisocial personality disorder )
|
| |
antisocial personality disorder
|
|
| |
antithrombin
|
| |
antituberculosis drug toxicity
|
| |
anxiety disorder
|
|
| | anxiety-related traits
( see anxiety disorder )
|
| |
aortic aneurysm
|
| |
aortic gradient
|
| |
aortic pulse wave velocity
|
| |
aortic regurgitation
|
| |
aortic stenosis
|
|
| | aortic stiffness
( see aortic stenosis )
|
| |
aortic valve sclerosis
|
| | aortic valve stenosis
( see aortic stenosis )
|
| | aortoarteritis
( see arteritis )
|
| |
APC resistance
|
| | Apert Syndrome
( see acrocephalosyndactyly )
|
| |
aphthous stomatitis
|
| |
aphthous stomatitis, recurrent
|
| | aplastic anemia
( see aplastic anemia, acquired )
|
| |
aplastic anemia, acquired
|
|
| |
apnea, post-succinylcholine
|
| |
apoA-IV
|
| |
apoA1
|
| |
apoA2
|
| |
apoAI
|
| |
apoB
|
| |
apoB-100
|
| |
ApoB-48
|
| |
apoC-III
|
| |
apoE
|
| |
apolipoproteins
|
| |
appendicitis
|
| |
areca quid chewing
|
| |
aromatic amino acid disturbances
|
| |
arrhythmia, cardiac
|
|
| |
arrhythmia, ventricular malignant
|
| | arrhythmias, reperfusion ventricular
( see arrhythmia, cardiac )
|
| |
arterial disease
|
|
| | arterial disease, lower extremity
( see arterial disease )
|
| |
arterial pulse wave velocities
|
| |
arterial stiffness
|
| |
arterial thrombosis
|
|
|
| |
arterial wall changes
|
|
| | arterial-wall changes
( see arterial wall changes )
|
| |
arteriovenous fistulas
|
|
| |
arteritis
|
| | arteritis, giant cell
( see giant cell arteritis )
|
| | artery obstructive disease, peripheral
( see peripheral vascular disease )
|
| |
arthritis
|
|
| |
arthritis, inflammatory
|
|
| | arthritis, juvenile
( see juvenile arthritis )
|
| | arthritis, juvenile idiopathic
( see juvenile arthritis )
|
| | arthritis, psoriatic
( see psoriatic arthritis )
|
| | arthritis, rheumatoid
( see rheumatoid arthritis )
|
| |
arthrofibrosis
|
| |
arthropathy with other bacterial diseases
|
| |
arthropathy, peripheral
|
|
| | asbestosis
( see asbestosis or pleural plaques )
|
| |
asbestosis or pleural plaques
|
| |
ascaris infection
|
| |
Asperger syndrome
|
|
| |
aspergillosis
|
| |
aspirin intolerance
|
| |
aspirin resistance
|
| |
asthma
|
|
| | asthma, alcohol-induced
( see alcoholism )
|
| | asthma, aspirin-induced
( see asthma, extrinsic )
|
| |
asthma, extrinsic
|
| |
ataxia
|
| |
ataxia (SCA)
|
|
| |
ataxia telangiectasia
|
| | Ataxia-Telangiectasia
( see spinocerebellar diseases, other )
|
| | Ataxia-Telangiectasia Variant 1 (ATV1)
( see spinocerebellar diseases, other )
|
| | Atelosteogenesis Type 2
( see musculoskeletal anomalies, other )
|
| |
atherosclerosis
|
|
| |
atherosclerosis of bypass graft, extremities
|
| | atherosclerosis, carotid
( see carotid artery damage )
|
| |
atherosclerosis, coronary
|
|
| |
atherosclerosis, generalized
|
|
|
| | atherosclerosis, morphological analysis of
( see atherosclerosis )
|
| | atherosclerotic lesions
( see atherosclerosis )
|
| |
atherothrombosis
|
|
| | atherothrombotic brain infarction
( see cerebral infarct, atherothrombotic )
|
| | atherothrombotic disease
( see atherothrombosis )
|
| |
athletic performance
|
| |
atopic dermatitis
|
|
| |
atopy
|
|
| | ATP7A-Related Copper Transport Disorders
( see congenital malformation syndromes, other )
|
| |
atrial fibrillation
|
|
| |
attachment disorder, disorganized
|
| |
attention deficit disorder
|
|
| |
attention deficit hyperactivity disorder
|
|
| | attention-deficit hyperactivity disorder
( see attention deficit hyperactivity disorder )
|
| |
auditory evoked potential
|
| |
autism
|
|
| | autoimmune diabetes
( see immune disorder, specified )
|
| |
autoimmune disorder
|
| | autoimmune liver disease
( see immune disorder, specified )
|
| | Autoimmune Lymphoproliferative Syndrome
( see autoimmune disorder )
|
| | autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy
( see autoimmune disorder )
|
| | autoimmune polyglandular syndrome
( see polyglandular dysfunction )
|
|
| | autoimmune thyroid disease
( see immune disorder, specified )
|
| |
autonomic disease
|
| |
Autosomal deletion syndromes
|
| | autosomal dominant polycystic kidney disease
( see polycystic kidney disease, autosomal dominant )
|
| | Autosomal Recessive Polycystic Kidney Disease
( see polycystic kidney disease, autosomal recessive )
|
| |
avascular necrosis
|
| | avascular osteonecrosis
( see osteonecrosis )
|
| |
azathioprine tolerance
|
| |
azoospermia
|
|
| |
| | B | Top |
| |
B cell function
|
| |
baldness
|
|
| |
Balkan endemic nephropathy
|
| | Bardet-Biedl Syndrome
( see congenital malformation syndromes, other )
|
| | Basal Ganglia Calcification
( see brain damage )
|
| | Batten Disease
( see Tay-Sachs disease )
|
| | Beare-Stevenson cutis gyrata syndrome
( see Bloom syndrome )
|
| | Becker muscular dystrophy
( see muscular dystrophy )
|
| |
Beckwith Wiedemann syndrome
|
| |
behavior disorder
|
| | behavior problems
( see conduct disorder )
|
| | behavioral disinhibition
( see conduct disorder )
|
| |
behavioral disorder
|
| |
Behcet's disease
|
|
| |
benzene toxicity
|
|
| |
berylliosis
|
|
| |
beryllium disease
|
| |
beryllium hypersensitivity
|
| | Best Disease
( see Leber's amaurosis, congenital )
|
| | best vitelliform macular dystrophy
( see retinal dystrophy )
|
| |
beta-carotene
|
| |
beta-cell function
|
| | beta-thalassemia
( see thalassemia )
|
| |
beta2 adrenoceptor expression
|
| |
bile duct cancer
|
|
| |
biliary atresia
|
|
| |
biliary lesions, ischemic
|
| |
bilirubin
|
| | binge eating
( see bulimia )
|
| | biotinidase deficiency
( see enzyme deficiency )
|
| | biplolar disorder
( see bipolar disorder )
|
| | bipolar affective disorder
( see bipolar disorder )
|
| | bipolar affective puerperal psychosis
( see psychosis, puerperal )
|
| |
bipolar disorder
|
|
| | birth defect
( see congenital anomalies )
|
| | birth defects
( see congenital anomalies )
|
| |
birth weight
|
|
| |
bladder cancer
|
|
| | bladder cancer, urinary
( see bladder cancer )
|
| |
bladder dysfunction
|
| | bleeding complications
( see hemorrhage )
|
| | bleeding events, warfarin therapy-related
( see hemorrhage )
|
| |
blepharospasm
|
|
| |
blood and blood forming organ disorders
|
|
| |
blood catalase levels
|
| |
blood flow
|
| |
blood group incompatibility
|
|
| |
blood pressure
|
| |
blood pressure, arterial
|
| |
blood pressure, submaximal exercise
|
| |
blood transfusion
|
| |
blood transfusion complications
|
| |
Bloom syndrome
|
|
| |
body composition variability
|
| |
body fat
|
| |
body height
|
| |
body mass
|
| |
body weight
|
| |
bone cancer
|
| |
bone density
|
| |
bone erosion
|
|
| | bone fractures
( see fractures )
|
| |
bone level, radiographic
|
| | bone loss
( see osteoporosis )
|
| |
bone marrow edema
|
| |
bone marrow transplant complications
|
| |
bone marrow transplantation
|
| |
bone mass
|
| | bone metabolism
( see bone erosion )
|
| |
bone mineral density
|
| |
bone responsiveness
|
| | bone turnover
( see bone erosion )
|
| |
bradykinin
|
| |
brain aneurysm
|
|
| |
brain atrophy
|
|
| | brain atrophy, alcoholic
( see brain atrophy )
|
| |
brain cancer
|
|
| |
brain damage
|
| |
brain damage, hypoxic
|
| |
brain electrical response
|
| |
brain hemorrhage
|
|
| | brain infarction
( see cerebral infarct )
|
| |
brain injury, traumatic
|
|
| |
brain lesions or calcifications
|
| | brain tumor
( see brain cancer )
|
| | Branchiootorenal Syndrome
( see urinary system anomalies )
|
| |
breast cancer
|
|
| | breast cancer tumour characteristics
( see breast cancer )
|
| | breast cancer, familial
( see breast cancer )
|
| |
breast cancer, male
|
|
| |
breast density
|
| |
bronchial hyperresponsiveness
|
| |
bronchiectasis
|
|
| |
bronchiectatic disease
|
| | bronchiolitis obliterans syndrome
( see lung transplant complications )
|
| |
bronchopulmonary aspergillosis
|
|
| |
bronchopulmonary dysphasia
|
| |
bronchopulmonary dysplasia
|
|
| |
brucellosis
|
|
| | Brugada syndrome
( see conduction disorder, other )
|
| |
Budd-Chiari syndrome
|
|
| |
Buerger's disease
|
|
| |
bufuralol 1'-hydroxylase activity
|
| |
bulimia
|
|
| | bulimia nervosa
( see bulimia )
|
| |
bullous pemphigoid
|
|
| |
bupropion pharmacokinetics
|
| | Burkitt Lymphoma
( see Burkitt's tumor or lymphoma )
|
| |
Burkitt's tumor or lymphoma
|
| |
butyrylcholinesterase activity
|
| |
| | C | Top |
| |
C-peptide
|
| |
C-peptide reaction, daily, urinary
|
| |
c-reactive protein
|
| | CADASIL
( see cerebral atherosclerosis )
|
| |
caffeine metabolite ratio
|
| |
calcitriol in hemodialysis patients, response to
|
| |
calcium
|
| | calcium nephrolithiasis
( see kidney stone disease )
|
| | calcium oxalate stones
( see urinary calculus )
|
| |
calcium, circulating
|
| | Canavan disease
( see leukodystrophy )
|
|
| |
cancer
|
|
| | cancer development in HIV infection
( see HIV )
|
| |
cancers of the lip, oral cavity, and pharynx
|
| | Candida
( see candidiasis )
|
| |
candidiasis
|
|
| | Carbamazepine hypersensitivity
( see drug hypersensitivity )
|
| |
carbohydrate metabolism disorders, other
|
| |
carbohydrate oxidation
|
| |
carbohydrate transport and metabolism disorders
|
| | carcinoma, basal cell
( see skin cancer, non-melanoma )
|
| |
cardiac bypass surgery complications
|
| |
cardiac cancer
|
| |
cardiac death
|
|
| |
cardiac disease
|
|
| | cardiac disease, chagasic
( see Chagas' disease, cardiac )
|
| | cardiac malformations, congenital
( see heart anomalies, congenital )
|
| | cardiac transplantation, rejection after
( see heart transplant complications )
|
| |
cardiomyopathy
|
|
| |
cardiomyopathy, alcoholic
|
|
| |
cardiomyopathy, hypertrophic
|
| | cardiomyopathy, idiopathic dilated
( see cardiomyopathy )
|
| | cardiomyopathy, nonfamilial hypertrophic
( see cardiomyopathy )
|
| |
cardiopulmonary bypass
|
| |
cardiorespiratory disease, preterm
|
| |
cardiotoxicity
|
| |
cardiovascular disease
|
|
| |
cardiovascular event, recurrent
|
| |
cardiovascular hemodynamics
|
| | cardiovascular mortality
( see cardiovascular disease )
|
| |
cardiovascular response to alcohol
|
| | cardiovascular risk factors
( see cardiovascular disease )
|
| |
carisoprodol metabolism
|
| |
carotenoids
|
| | carotid and femoral artery stiffness
( see fibromuscular dysplasia (FMD) )
|
| |
carotid artery damage
|
|
| |
carotid artery distensibility
|
| |
carotid artery intima-media thickness
|
| | carotid artery stenosis
( see carotid artery damage )
|
| | carotid atherosclerosis
( see carotid artery damage )
|
| |
carotid intima-media thickness
|
| | carotid plaque
( see carotid artery damage )
|
| |
carpal tunnel syndrome
|
| | carpal-tunnel syndrome
( see carpal tunnel syndrome )
|
| | cataplexy
( see narcolepsy )
|
| | cataract
( see cataract, senile )
|
| |
cataract, presenile
|
| |
cataract, senile
|
|
| |
catecholestrogen formation
|
| |
catecholestrogen metabolism
|
| |
catheter interventions
|
| |
celiac disease
|
|
| |
cell-surface B7 expression
|
| | cerebral aging
( see cerebral degeneration, senile )
|
| |
cerebral amyloid angiopathy
|
|
| | cerebral amyloid peptide deposition
( see cerebral degeneration )
|
| |
cerebral arteriopathy
|
|
| |
cerebral atherosclerosis
|
| | cerebral atrophy
( see cerebral degeneration )
|
| |
cerebral circulation
|
| |
cerebral degeneration
|
| |
cerebral degeneration, senile
|
| |
cerebral infarct
|
|
| |
cerebral infarct, atherosclerotic
|
| |
cerebral infarct, atherothrombotic
|
|
|
| | cerebral infarction
( see cerebral infarct )
|
| | cerebral infarction, atherosclerotic
( see cerebral infarct )
|
| |
cerebral ischemia
|
| | Cerebral lipidoses
( see Tay-Sachs disease )
|
| |
cerebral palsy
|
|
| |
cerebral palsy, hemiplegic
|
|
| | cerebral sinovenous thrombosis
( see cerebral venous thrombosis )
|
| |
cerebral venous thrombosis
|
|
|
| | cerebral white matter hyperintensities
( see brain damage )
|
| | cerebral white matter lesions
( see brain damage )
|
| | cerebrovascular disease
( see cerebral arteriopathy )
|
| |
cerebrovascular disease, ischemic
|
|
| |
cerebrovascular infart
|
| |
ceruloplasmin
|
| |
cervical artery dissection, spontaneous
|
|
|
| |
cervical cancer
|
|
| |
cervical dysplasia
|
|
| | cervical dystonia
( see dystonia, cervical )
|
| |
cervical incompetence
|
|
| | cervical squamous intraepithelial lesions
( see cervical dysplasia )
|
| |
Chagas' disease
|
|
| |
Chagas' disease, cardiac
|
| |
Char Syndrome
|
| |
Charcot-Marie-Tooth disease
|
|
| | Charcot-Marie-Tooth neuropathy type 2E/1F
( see Charcot-Marie-Tooth disease )
|
| |
chemotherapy toxicity
|
| |
Chlamydia
|
|
| | Chlamydia infection
( see Chlamydia )
|
| |
Chlamydia pneumoniae infection
|
|
| |
chloride transport
|
| |
choesterol absorption
|
| |
cholangiocarcinoma
|
|
| | cholangitis, primary sclerosing
( see cholangitis, sclerosing )
|
| |
cholangitis, sclerosing
|
|
| | cholecystolithiasis
( see cholelithiasis )
|
| |
cholelithiasis
|
|
| |
cholestasis
|
|
| |
cholesterol
|
| |
cholesterol efflux
|
| |
cholesterol, HDL
|
| |
cholesterol, LDL
|
| |
cholesterol, response to
|
| |
cholesterol, total
|
| |
cholesterol, VLDL
|
| |
cholesteryl ester transfer protein
|
| |
cholinesterase activity
|
| |
chondrocalcinosis
|
|
| |
chondrodystrophy
|
| | Choreoacanthocytosis
( see muscular dystrophy, congenital hereditary )
|
| |
chorioamnionitis
|
| |
chromosomal anomalies
|
| | chronic beryllium disease
( see berylliosis )
|
| |
chronic bronchopulmonary diseases
|
| |
chronic disease burden
|
| |
chronic fatigue
|
| |
chronic fatigue syndrome
|
| |
chronic lung disease
|
| | chronic obstructive pulmonary disease
( see chronic obstructive pulmonary disease/COPD )
|
| |
chronic obstructive pulmonary disease/COPD
|
|
| |
chronic toxic encephalopathy
|
| |
circadian variability
|
|
| |
cirrhosis
|
|
| | cirrhosis, alcohol-induced
( see cirrhosis, alcoholic )
|
| |
cirrhosis, alcoholic
|
|
| |
cirrhosis, biliary primary
|
|
| | cirrhosis, primary biliary
( see cirrhosis, biliary primary )
|
| |
citalopram metabolism
|
| |
citrullinemia
|
| | citrullinemia, adult-onset type II
( see citrullinemia )
|
| | cleft lip
( see cleft lip without cleft palate )
|
| |
cleft lip with cleft palate
|
|
| | cleft lip with or without cleft palate
( see cleft lip with cleft palate )
|
| |
cleft lip without cleft palate
|
|
| |
cleft palate
|
|
| | cleft palate, isolated
( see cleft palate )
|
| |
clomipramine metabolism
|
| |
clozapine, response to
|
| |
cluster headache
|
|
| | coagulation
( see coagulation disorder )
|
| |
coagulation disorder
|
|
| |
cobalamin
|
| |
cocaine abuse
|
|
| |
cocaine dependence
|
|
| | cocaine dependence/abuse
( see cocaine dependence )
|
| | Cockayne Syndrome
( see congenital malformation syndromes, other )
|
| | cognition, prefrontal
( see memory disturbance )
|
| | cognitive ability
( see memory disturbance )
|
| | cognitive decline
( see memory disturbance )
|
| | cognitive function
( see memory disturbance )
|
| | cognitive impairment
( see memory disturbance )
|
| |
cold, common
|
| | colestasis of pregnancy, intrahepatic
( see cholestasis )
|
| | colitis
( see inflammatory bowel disease )
|
| |
collagen metabolism
|
| | colon cancer
( see colorectal cancer )
|
|
| | colon polyposis
( see colon polyps )
|
| |
colon polyps
|
|
| |
colorectal cancer
|
|
| | colorectal cancer, hereditary nonpolyposis
( see colorectal cancer )
|
| | colorectal cancer, nonpolyposis
( see colorectal cancer )
|
| | colorectal polyps
( see colon polyps )
|
| | colorectal polyps, dysplasia of
( see colon polyps )
|
| |
colostomy or enterostomy infection
|
| | common cold
( see cold, common )
|
| |
common variable immunodeficiency
|
|
| |
complement component concentration
|
| |
complete blood count
|
| |
conduct disorder
|
|
| |
conduction disorder, other
|
| | cone-rod dystrophy
( see Stargardt disease )
|
| | congenital absence of the uterus and vagina
( see congenital absence of uterus )
|
| |
congenital absence of uterus
|
| | congenital adrenal hyperplasia
( see adrenal hyperplasia, congenital )
|
| |
congenital anomalies
|
|
| |
congenital anomaly
|
| | congenital bilateral absence of the vas deferens
( see absence of vas deferens, congenital )
|
| | congenital bilateral absence of vas deferens
( see absence of vas deferens, congenital )
|
| | congenital disorders of glycosylation
( see carbohydrate metabolism disorders, other )
|
| | congenital hearlng impairment
( see hearing loss )
|
| |
congenital heart block
|
| | congenital heart disease
( see heart anomalies, congenital )
|
| | congenital hypothyroidism
( see hypothyroidism, congenital )
|
| | Congenital Ichthyosis
( see ichthyosis congenita )
|
| |
congenital malformation syndromes, other
|
| | Congenital Muscular Dystrophy
( see Nemaline body disease )
|
| |
congenital musculoskeletal anomalies, other
|
| | congenital nephrosis
( see nephrosis )
|
| |
congestive heart failure
|
|
| |
Conn's syndrome
|
|
| |
connective tissue disease, mixed
|
|
| | conotruncal heart defect
( see conotruncal heart defects )
|
| |
conotruncal heart defects
|
|
| |
contact dermatitis, chemical products
|
| | contusion index
( see contusion, brain )
|
| |
contusion, brain
|
| |
corneal dystrophy
|
| |
coronary artery aneurysm
|
| | coronary artery atherosclerosis
( see atherosclerosis, coronary )
|
| |
coronary artery bypass
|
| |
coronary artery bypass graft
|
| |
coronary artery bypass grafting
|
| | coronary artery calcification
( see atherosclerosis, coronary )
|
| | coronary artery disease
( see atherosclerosis, coronary )
|
| | coronary artery disease, occlusive
( see atherosclerosis, coronary )
|
| | coronary artery ectasia
( see aortic aneurysm )
|
| |
coronary artery luminal dimensions
|
| |
coronary artery reactivity
|
| | coronary artery spasm
( see peripheral vascular disease )
|
| | coronary artery stenosis
( see atherosclerosis, coronary )
|
| |
coronary artery vasomotility
|
| | coronary atherosclerosis
( see atherosclerosis, coronary )
|
| |
coronary blood flow
|
| |
coronary calcification
|
|
| | coronary death
( see cardiac death )
|
| | coronary disease
( see heart disease, ischemic )
|
| |
coronary endothelial vasodilator function
|
| | coronary endothelial vasomotor dysfunction
( see cardiomyopathy )
|
| |
coronary flow velocity
|
| | coronary heart disease
( see heart disease, ischemic )
|
| | coronary heart disease risk factors
( see heart disease, ischemic )
|
| | coronary heart disease, premature
( see heart disease, ischemic )
|
| | coronary heart disease, transplant associated
( see heart disease, ischemic )
|
| |
coronary insufficiency
|
| | coronary reactivity
( see cardiovascular disease )
|
| |
coronary revascularization
|
| |
coronary spasm
|
| |
coronary stent outcome
|
| | coronary syndromes, acute
( see acute coronary syndrome )
|
| | coronary thrombosis
( see thromboembolism, venous )
|
| | coronary vascular endothelial dysfunction
( see coronary vasculopathy )
|
| | coronary vascular tone
( see coronary vasculopathy )
|
| |
coronary vasculopathy
|
|
| |
coronavirus infection
|
| |
cortisol
|
| |
cortisol response to opioid receptor blockade
|
| |
cortisol secretion
|
| |
cortisol, salivary
|
| |
cough
|
|
| | cough, angiotensin-converting enzyme inhibitor-related
( see cough )
|
| | cough, chronic nonproductive
( see cough )
|
| | cough, persistent dry
( see cough )
|
| | Cowden Syndrome
( see hamartomas )
|
| | craniofacial dysostosis
( see craniosynostosis )
|
| | Craniosynostosis
( see craniosynostosis )
|
|
| |
creatinine
|
| |
creatinine clearance
|
| | Creutzfeldt-Jakob disease
( see Jakob-Creutzfeldt disease )
|
| |
Crigler-Najjar syndrome
|
| |
Crohn's disease
|
|
| |
CrossLaps, urinary
|
| | Crouzon syndrome
( see craniosynostosis )
|
| | Crouzonodermoskeletal syndrome
( see Bloom syndrome )
|
| |
cryptochidism
|
| | cryptorchidism
( see undescended testis )
|
| |
cryptosporidiosis
|
|
| |
CSF cortisol levels
|
| |
cutaneous adverse drug reaction
|
| | cutaneous malignant melanoma
( see melanoma )
|
| |
cutaneous neonatal lupus
|
| | Cyclic Neutropenia
( see agranulocytosis )
|
| |
cyclophosphamide bioactivation
|
| |
CYP1A1 inducibility
|
| |
CYP1A1 levels in lung tissue
|
| |
CYP1A2 activity
|
| |
CYP2A6
|
| |
CYP2C19 activity
|
| |
CYP2C9 activity
|
| |
CYP2D6 activitiy
|
| |
CYP3A activity
|
| |
CYP3A4 activity
|
| |
CYP3A5 expression
|
| |
CYP3A5 levels
|
| |
cystathionine beta-synthase deficiency
|
| |
cystatin C
|
| |
cystatin SA protein
|
| |
cysteine
|
| |
cysteine levels
|
| |
cystic fibrosis
|
|
| | Cystinosis
( see cystinuria )
|
| |
cystinuria
|
|
| |
Cytogenetic studies
|
| |
cytokine production
|
| |
cytokine release after cardiopulmonary bypass surgery
|
| |
cytokine secretion
|
| |
cytokine synthesis
|
| |
cytokines
|
| |
cytomegalovirus
|
| |
cytomegalovirus retinitis
|
| |
| | D | Top |
| |
deafness
|
|
| | deafness, congenital
( see deafness )
|
| | deafness, nonsyndromic
( see deafness )
|
| |
degeneration of discs, intervertebral
|
| | degeneration of intervertebral discs
( see degeneration of discs, intervertebral )
|
| |
dehydroepiandrosterone
|
| |
dehydroepiandrosterone sulphate
|
| | delayed sleep phase syndrome
( see sleep disorders )
|
| | delirium tremens, alcohol withdrawal-induced
( see delirium tremens, alcohol-induced )
|
| |
delirium tremens, alcohol-induced
|
|
| |
delusional disorder
|
|
| |
dementia
|
|
| |
dementia in other conditions
|
|
| | dementia, AIDS
( see dementia in other conditions )
|
| |
dementia, arteriosclerotic
|
| | dementia, frontotemporal
( see dementia )
|
| | dementia, HIV
( see dementia in other conditions )
|
| | dementia, multi-infarct
( see dementia, arteriosclerotic )
|
| | dementia, semantic
( see dementia )
|
| | dementia, vascular
( see dementia, arteriosclerotic )
|
| |
dengue fever
|
| |
dengue hemorrhagic fever
|
|
| |
dental implants
|
| | depressed suicide
( see depression )
|
| |
depression
|
|
| | depression, Alzheimer's disease related
( see depression )
|
| | depression, late onset
( see depression )
|
| | depression, manic
( see manic depression )
|
| |
depressive disorder, major
|
|
| | depressive episode, major
( see depressive disorder, major )
|
| | depressive symptoms
( see depression )
|
| |
dermal erythema
|
| |
dermatitis and eczema
|
|
| | dermatitis syndrome
( see dermatitis and eczema )
|
| | dermatitis, atopic
( see atopic dermatitis )
|
| | dermatomyosis
( see dermatomyositis )
|
| |
dermatomyositis
|
|
| |
DES-exposed offspring
|
|
| |
desipramine pharmacokinetics
|
| |
desmoid tumors
|
|
| |
dextromethorphan O-demethylation activities
|
| |
DHEA
|
| |
diabetes
|
|
| | diabetes manifestation
( see diabetes )
|
| | diabetes, autoimmune
( see diabetes )
|
| |
diabetes, gestational
|
|
| | diabetes, latent autoimmune
( see diabetes, type 1 )
|
| | diabetes, malnutrition-modulated
( see diabetes )
|
| | diabetes, maternally inherited
( see diabetes, neonatal )
|
| |
diabetes, neonatal
|
| |
diabetes, neurological manifestations
|
|
| | diabetes, NOS
( see diabetes )
|
| |
diabetes, ophthalmic manifestations
|
| | diabetes, pancreatic
( see diabetes )
|
| | diabetes, post-renal transplant
( see diabetes )
|
| |
diabetes, type 1
|
|
| |
diabetes, type 2
|
|
| | diabetes, unspecified
( see diabetes )
|
| | diabetes-associated autoantibodies
( see diabetes )
|
| |
diabetic nephropathy
|
|
| |
diabetic neuropathy
|
| |
diabetic polyneuropathy
|
| |
diaphragmatic hernia
|
| | Diaphyseal Aclasis
( see chondrodystrophy )
|
| | Diastrophic Dysplasia
( see congenital musculoskeletal anomalies, other )
|
| |
diclofenac metabolism
|
| |
diclofenac pharmacokinetics and pharmacodynamics
|
| |
dietary cholesterol, response to
|
| |
dietary fat, response to
|
| |
DiGeorge syndrome
|
| |
DiGeorges syndrome
|
|
| |
digoxin, bioavailability
|
| |
digoxin, serum concentration
|
| |
dihydropyrimidine dehydrogenase level
|
| |
dihydropyrmidine dehydrogenase
|
| |
dioxin concentration
|
| |
disc degeneration
|
| |
disc degeneration, lumbar spine
|
|
| |
disc disease, lumbar
|
| |
disorders of purine and pyrimidine metabolism, other
|
| | disorganized attachment behavior
( see attachment disorder, disorganized )
|
| | diurnal preferences
( see circadian variability )
|
| |
DNA adducts
|
| |
DNA adducts, aromatic
|
| |
DNA damage
|
| |
DNA damage, biomarkers of
|
| |
DNA damage, oxidative
|
| |
DNA methylation
|
| |
DNA repair
|
| |
DNA repair capacity
|
| |
DNA strand breakage
|
| | DNA-protein crosslinks, breast cancer related
( see breast cancer )
|
| |
dopamine beta-hydroxylase activity
|
| |
dopamine D2 receptor density
|
| | Down syndrome
( see Down's syndrome )
|
| |
Down's syndrome
|
| |
doxepin metabolism
|
| |
dronedarone pharmacokinetics
|
| |
drug hypersensitivity
|
|
|
| |
drug metabolism
|
| | Duchenne muscular dystrophy
( see muscular dystrophy )
|
| |
duodenal polyps
|
| |
duodenal ulcer
|
|
| |
Dupuytren's disease
|
|
| |
dust mite, sensitization to
|
| |
dwarfism
|
| |
dysautonomia, familial
|
| |
dysbetalipoproteinemia
|
| |
dyslexia
|
| |
dyslipemia
|
| | dyslipidemia
( see lipid metabolism disorders )
|
| |
dysmenorrhea
|
|
| |
dyspepsia
|
|
| | dysphoria, premenstrual
( see premenstrual syndrome )
|
| |
dysplasia, hip
|
| | dysplastic nevi
( see nevi )
|
| |
dysthymia
|
| |
dysthymic disorder
|
| |
dystonia
|
| |
dystonia, cervical
|
|
| | dystonia, early onset primary
( see dystonia, torsion )
|
| |
dystonia, focal
|
| |
dystonia, primary
|
| |
dystonia, primary torsion
|
| |
dystonia, torsion
|
| | dystrophic epidermolysis bullosa
( see Epidermolysis bullosa )
|
| |
| | E | Top |
| |
E-selectin
|
| |
E. coli infection
|
| | E. coli O157:H7 infection
( see E. coli infection )
|
| |
ear disorders
|
| |
eating behavior
|
| | eating disorder
( see eating disorders )
|
| |
eating disorder, unspecified
|
| | eating disorders
( see eating disorder, unspecified )
|
|
|
| |
ECG
|
| |
echinococcosis
|
|
| |
eclampsia
|
|
| | eczema
( see dermatitis and eczema )
|
| |
effects of high altitude, other
|
| |
Ehlers-Danlos syndrome
|
|
| |
EKG, abnormal
|
| |
electrocardiogram PR interval
|
| |
electrolyte levels
|
| |
elite endurance
|
| |
Ellis-van Creveld syndrome
|
|
| |
embryonic development
|
| |
emphysema
|
|
| |
encephalocele
|
|
| |
encephalomyopathy, mitochondrial
|
| | encephalopathies, transmissible spongiform
( see Jakob-Creutzfeldt disease )
|
| |
encephalopathy, unspecified
|
| |
endocrine disorders, other
|
| |
endocrine response to alcohol
|
| |
endometrial cancer
|
|
| |
endometriosis
|
|
| | endothelial cell damage
( see vascular disease )
|
| |
endothelial function
|
| |
endothelin-1
|
| |
endothelium dependent dilatation
|
| |
endotoxemia
|
| |
endotoxin response
|
| |
endotoxin, response to
|
| |
endurance
|
| |
endurance performance
|
| |
endurance, elite
|
| |
energy expenditure
|
| |
enlarged parietal foramina/cranium bifidum
|
| | enterocolitis, necrotizing
( see necrotizing enterocolitis )
|
| |
enzyme deficiency
|
| |
enzyme levels, abnormal
|
| |
eosinophil counts
|
| | ephelides
( see freckles and solar lentigines )
|
| |
epidermodysplasia verruciformis
|
| |
Epidermolysis bullosa
|
| | Epidermolysis Bullosa Simplex
( see Epidermolysis bullosa )
|
| |
epilepsy
|
|
| |
epilepsy,
|
| | epilepsy, idiopathic generalized
( see epilepsy )
|
| |
epilepsy, temporal lobe
|
|
| |
epitestosterone
|
| |
Epstein-Barr virus
|
|
| | Epstein-Barr virus infection
( see Epstein-Barr virus )
|
| |
erectile dysfunction
|
|
| |
erythema nodosum
|
| | erythema nodosum, sarcoidosis-associated
( see erythema nodosum )
|
| |
erythrocyte hemoglobin content
|
| |
erythrocyte histamine N-methyltransferase activity
|
| |
erythrocyte volume
|
| |
erythrocytosis, idiopathic
|
| |
erythropoietin requirement
|
| |
esophageal cancer
|
|
| |
esophageal varices
|
|
| |
esophagitis
|
|
| |
essential tremor
|
|
| |
estradiol
|
| |
estrogen
|
| |
estrogen metabolism
|
| |
estrogens
|
| | ethylene oxide metabolism/toxicity
( see ethylene oxide toxicity )
|
| |
ethylene oxide toxicity
|
| |
exercise
|
| |
exercise capacity
|
| |
exercise tolerance
|
| | externalizing behavior problems
( see conduct disorder )
|
| |
extrapyramidal disease/abnormal movement disorder
|
| | extrapyramidal side effects
( see extrapyramidal disease/abnormal movement disorder )
|
| |
eye cancer
|
| |
eye movement disturbances
|
|
| |
| | F | Top |
| | f12 plasma deficiency, moderate
( see Factor XII deficiency )
|
| | Fabry Disease
( see lipidoses )
|
| | facial flushing
( see flushing, facial )
|
| | Facioscapulohumeral Muscular Dystrophy
( see muscular dystrophy )
|
| |
factor 13 activity
|
| | factor V Leiden
( see coagulation disorder )
|
| | factor V Leiden positivity
( see coagulation disorder )
|
| |
factor VII
|
| | factor VII antigen
( see coagulation disorder )
|
| | factor VII coagulant activity
( see coagulation disorder )
|
| |
Factor XII deficiency
|
| |
factor XII levels
|
| |
fallopian cancer
|
| |
fallopian tube cancer
|
| | familial adenomatous polyposis
( see colon polyps )
|
| | familial dysautonomia
( see dysautonomia, familial )
|
| | familial hemiplegic migraine
( see migraine, hemiplegic )
|
| | familial hypercholesterolemia
( see hypercholesterolemia )
|
| |
Familial Mediterranean Fever
|
|
| |
familial periodic paralysis
|
| | Fanconi Anemia
( see Fanconi's anemia )
|
| |
Fanconi's anemia
|
|
| |
fasting blood sugar
|
| | fat mass
( see obesity, localized )
|
| |
fat oxidation
|
| | fat, abdominal
( see obesity, localized )
|
| |
fatal drug intoxication
|
| |
fatigue
|
| |
fatty acid
|
| |
fatty acid disorder
|
| | fatty liver
( see liver disease, nonalcoholic fatty )
|
| |
felty's syndrome
|
|
| |
femoral neck geometry
|
| |
ferritin
|
| |
ferroxidase
|
| |
fetal alcohol syndrome
|
|
| |
fetal growth
|
| |
fetal growth, poor
|
| |
fetal hemoglobin
|
| |
fetal loss, late
|
|
| | FGFR3-associated coronal synostosis
( see craniosynostosis )
|
| |
fibrin D-dimer
|
| |
fibrinogen
|
| |
fibrinolytic activities
|
| |
fibromuscular dysplasia (FMD)
|
|
| |
fibromyalgia
|
|
| | fibrosis, idiopathic pulmonary
( see pulmonary fibrosis )
|
| |
fibrosis, radiation induced
|
|
| |
filiariasis
|
| | fistulas, dural arteriovenous
( see arteriovenous fistulas )
|
| |
flow-mediated dilation of the brachial artery
|
| |
flubiprofen metabolism
|
| | fluorouracil toxicity
( see antineoplastic and immunosuppressive toxicity )
|
| |
flushing, facial
|
| | fluvastatin, clinical events with
( see antilipemic toxicity )
|
| |
fluvoxamine metabolism
|
| |
folate
|
| | folate pool in gastrointestinal cancer
( see gastrointestinal cancer )
|
| |
folate, erythrocyte
|
| |
folic acid
|
| |
follicle stimulating homone
|
| | food allergy
( see allergy, food )
|
| |
food consumption
|
| | fracture risk
( see fractures )
|
| |
fracture, nonvertebral
|
| |
fractures
|
|
| |
fractures, vertebral
|
|
| |
Fragile X Syndrome
|
|
| |
freckles and solar lentigines
|
| | Free Sialic Acid Storage Disorders
( see carbohydrate metabolism disorders, other )
|
| |
Freidreich ataxia
|
| |
Friedreich's ataxia
|
| | Friedreichs ataxia
( see Friedreich's ataxia )
|
| |
frontal lobe disorder
|
| | frontal lobe function
( see frontal lobe disorder )
|
| | frontotemporal degeneration
( see cerebral degeneration )
|
| | frontotemporal lobar degeneration
( see cerebral degeneration )
|
| |
FSH, basal
|
| |
fungal disease, superficial
|
| |
| | G | Top |
| |
G6PD deficiency
|
|
| | Galactokinase deficiency
( see galactosemia )
|
| |
galactosemia
|
|
| |
gallbladder cancer
|
|
| | gallstones
( see cholelithiasis )
|
| |
gamma-GTP level
|
| |
gamma-tocopherol
|
| | gastric cancer
( see stomach cancer )
|
| | gastric cancer, Epstein-Barr virus-associated
( see Epstein-Barr virus )
|
| | gastric cardia adenocarcinoma
( see gastric cardia cancer )
|
| |
gastric cardia cancer
|
|
| | gastric cardiac cancer
( see gastric cardia cancer )
|
| |
gastric disease
|
|
| |
gastric polyps
|
| |
gastric ulcer
|
|
| | gastric ulceration
( see gastric ulcer )
|
| |
gastritis
|
|
| |
gastritis, chronic atrophic
|
|
| | gastritis, Helicobacter pylori-induced
( see gastritis, other specified )
|
| |
gastritis, other specified
|
| |
gastroesophageal cancer
|
| | gastroesophageal reflux disease
( see gastroesophageal reflux disease/GERD )
|
| |
gastroesophageal reflux disease/GERD
|
| |
gastrointestinal cancer
|
|
| |
gastrointestinal disorders
|
| | Gaucher disease
( see lipidoses )
|
| |
gender ratio
|
| |
genotoxicity
|
| |
giant cell arteritis
|
|
| |
Gilbert syndrome
|
|
| | Gilbert's syndrome
( see Gilbert syndrome )
|
| |
gingival overgrowth
|
|
| |
Gitelman's syndrome
|
| |
Glanzmann thrombasthenia
|
| |
glaucoma
|
|
|
| |
glaucoma, early-onset
|
|
| |
glaucoma, normal tension
|
| |
glaucoma, primary congenital
|
| |
glaucoma, primary open-angle
|
|
| |
glaucoma, unspecified
|
| | glioblastoma multiforme
( see brain cancer )
|
| | glioma
( see brain cancer )
|
| |
globulin
|
| |
glomerular filtration rate
|
| |
glomerular immune deposition
|
|
| |
glomerular microthrombus
|
|
| | glomerulonephritis
( see nephropathy )
|
| |
glomerulonephritis, Hepatitis B virus-associated
|
| | glomerulopathy, diabetic
( see diabetic nephropathy )
|
| |
glomerulosclerosis, focal
|
|
| |
glucocorticoid sensitivity
|
| |
glucocorticoids
|
| |
glucose
|
| |
glucose disposal
|
| | Glucose Galactose Malabsorption
( see lactose intolerance )
|
| |
glucose metabolism
|
| |
glucose reponse
|
| |
glucose tolerance
|
| | Glucose Transporter Type 1 Deficiency Syndrome
( see carbohydrate transport and metabolism disorders )
|
| |
glucosuria
|
|
| |
glucuronidation
|
| |
glutamic acid decarboxylase antibodies
|
| |
glutamic pyruvate transaminase
|
| | Glycine Encephalopathy
( see encephalopathy, unspecified )
|
| |
glycogen storage disease
|
|
| | glycogen storage disease type IIIA
( see glycogen storage disease )
|
| |
glycogen synthase protein in muscle
|
| |
glycohemoglobin A1
|
| |
glycophorin A somatic mutations
|
| |
goiter
|
|
| |
gonadal dysgenesis
|
| |
Goodpasture's disease
|
| | Gorlin Syndrome
( see congenital anomaly )
|
| |
gout
|
| | GRACILE syndrome
( see metabolism disorders )
|
| |
graft acceptance, liver
|
| | graft loss
( see kidney transplant complications )
|
| | graft occlusion, atherosclerotic
( see atherosclerosis of bypass graft, extremities )
|
| | graft rejection, liver
( see liver transplant complications )
|
| |
graft survival after kidney transplant
|
| | graft vascular disease
( see vascular disease )
|
| | graft versus host disease
( see bone marrow transplant complications )
|
| | graft-versus-host disease
( see bone marrow transplant complications )
|
| | graft-vs-host disease
( see bone marrow transplant complications )
|
| |
gram-negative infection
|
|
| | granulomatosis, Wegener's
( see Wegener's granulomatosis )
|
| | Graves
( see Graves' disease )
|
| |
Graves' disease
|
|
| |
growth
|
| |
Guillain-Barre syndrome
|
|
| |
gyrate atrophy of the choroid
|
|
| |
| | H | Top |
| |
H. pylori infection
|
|
| |
hallucinations
|
|
| |
haloperidol, plasma
|
| |
hamartomas
|
|
| |
hantavirus
|
| |
haptoglobin development
|
| |
harm avoidance
|
| | Hashimoto thyroiditis
( see thyroiditis, chronic lymphocytic )
|
| | Hashimoto's thyroiditis
( see thyroiditis, chronic lymphocytic )
|
| |
Hb F
|
| |
HbA(1c)
|
| |
HbA1c
|
| |
HBs Ag
|
| |
head and neck cancer
|
|
| | head cancer
( see head and neck cancer )
|
| |
head circumference
|
| |
head injury
|
| | hearing impairment
( see hearing loss/deafness )
|
| |
hearing loss
|
| | hearing loss, nonsyndromic sensorineural
( see hearing loss, sensorineural nonsyndromic )
|
| | hearing loss, sensorineural
( see hearing loss, sensorineural nonsyndromic )
|
| |
hearing loss, sensorineural nonsyndromic
|
|
| |
hearing loss/deafness
|
|
| |
heart anomalies, congenital
|
|
|
| |
heart disease, ischemic
|
|
| |
heart failure
|
|
| | heart failure with aldosterone escape, chronic
( see hormone disturbance )
|
| | heart muscle disease, alcoholic
( see alcoholism )
|
| |
heart rate
|
| |
heart rate, resting
|
| |
heart rate, sumaximal exercise
|
| |
heart transplant complications
|
|
| | heart transplant, rejection after
( see heart transplant complications )
|
| | heart transplantation, allograft rejection after
( see heart transplant complications )
|
| |
height
|
| | Helicobacter pylori infection
( see H. pylori infection )
|
| |
HELLP syndrome
|
|
| |
hematologic cancer
|
| |
hematology indices
|
| |
hematopoietic cell transplantation
|
| | hematopoietic outcomes, lead exposure related
( see lead toxicity )
|
| |
hematopoietic progenitor cells, mobilization of
|
| |
hematopoietic stem cell transplantation
|
| |
hemochromatosis
|
|
| |
hemodialysis
|
| |
hemodialysis graft failure
|
| |
hemodialysis mortality risk
|
| |
hemoglobin A(1c)
|
| |
hemoglobin disorders
|
|
| |
hemoglobin, reduced glycosylated
|
| | hemoglobinopathies
( see hemoglobin disorders )
|
| |
hemolysis
|
|
| |
hemolytic anemias, acquired
|
| | hemolytic disease of the newborn
( see hemolytic disease, newborn )
|
| |
hemolytic disease, newborn
|
| |
hemolytic uremic syndrome
|
|
| |
hemophilia
|
|
| |
hemophilia B
|
|
| |
hemorrhage
|
| | hemorrhage, intracerebral
( see brain hemorrhage )
|
| |
hemorrhage, intracranial
|
| | hemorrhage, large intraventricular
( see brain hemorrhage )
|
| |
hemorrhagic telangiectasia, hereditary
|
|
| |
hemostasis
|
| | Henoch-Schonlein purpura
( see purpura, allergic )
|
| | hepatic failure, fulminant
( see liver failure, acute )
|
| |
hepatic GSTA1/GSTA2 expression
|
| |
hepatic lipase activity
|
| |
hepatic veno-occlusive disease
|
| |
hepatitis
|
|
| | hepatitis B
( see hepatitus B )
|
| | hepatitis B infection
( see hepatitus B )
|
| |
hepatitis B surface antigen status
|
| |
hepatitis B vaccination, humoral immune response
|
| |
hepatitis B, chronic
|
| |
hepatitis C
|
|
| | hepatitis C infection
( see hepatitis C )
|
| | hepatitis C viral load
( see hepatitis C )
|
| | hepatitis C virus infection
( see hepatitis C )
|
| |
hepatitis C, chronic
|
|
| | hepatitis type 1, autoimmune (AIH-1)
( see immune disorder, specified )
|
| | hepatitis, antituberculosis drug-induced
( see hepatitis )
|
| | hepatitis, autoimmune
( see immune disorder, specified )
|
| |
hepatitis, chronic
|
|
|
| |
hepatitis, neonatal
|
| | hepatitis, neonatal associated with cholestasis
( see hepatitis, neonatal )
|
| |
hepatitus B
|
| | hepatocellular carcinoma
( see liver cancer )
|
| | hepatotoxicity
( see antituberculosis drug toxicity )
|
|
| | hereditary hemochromatosis
( see hemochromatosis )
|
| | hereditary hemorrhagic telangiectasia
( see hemorrhagic telangiectasia, hereditary )
|
| | hereditary medullary thyroid carcinoma
( see thyroid cancer )
|
| |
Hereditary Neuropathy with liability to Pressure P
|
| | hereditary nonpolyposis colorectal cancer (HNPCC)
( see colorectal cancer )
|
| |
hereditary sensory neuropathy
|
| | Hereditary Sensory Neuropathy Type I
( see hereditary sensory neuropathy )
|
| |
hereditary spastic paraplegia
|
|
| |
heroin abuse
|
|
| |
heroin addiction
|
|
| | heroin dependence
( see heroin addiction )
|
| | heroin use
( see heroin abuse )
|
| |
herpes encephalitis
|
| | herpes simplex encephalitis
( see herpes encephalitis )
|
| |
herpes simplex virus
|
| |
herpes zoster
|
| | herpes zoster infection
( see herpes zoster )
|
| |
high altitude performance
|
| |
high altitude pulmonary edema
|
| | high-altitude pulmonary edema
( see effects of high altitude, other )
|
| |
high-altitude tolerance
|
| | hip dysplasia
( see dysplasia, hip )
|
| | hippocampal atrophy
( see brain atrophy )
|
| | Hirschsprung Disease
( see Hirschsprung's disease )
|
| |
Hirschsprung's disease
|
|
| | Hirschsprungs disease
( see Hirschsprung's disease )
|
| |
hirsutism
|
|
| |
histamine N-methyltransferase activity
|
| |
HIV
|
|
| | HIV dementia
( see HIV )
|
| | HIV disease progression
( see HIV )
|
| |
HIV encephalitis
|
| | HIV infection
( see HIV )
|
| | HIV RNA levels
( see HIV )
|
| | HIV viral load
( see HIV )
|
| | HIV, perinatal transmission of
( see HIV )
|
| | HIV, susceptibility to
( see HIV )
|
| |
HLA-DR2 specificity
|
| |
HLA-G
|
| | Hodgkin lymphoma
( see Hodgkin's lymphoma )
|
| |
Hodgkin's disease
|
|
| |
Hodgkin's lymphoma
|
| |
Holoprosencephaly
|
|
| |
homocysteine
|
| |
homocystine
|
| |
homocystinuria
|
|
| |
hormone disturbance
|
|
| |
hormone levels
|
| |
hormones
|
| |
HTLV-1 associated myelopathy/tropical spastic paraparesis
|
| |
HTLV-1 infection
|
|
| | HTLV-1-associated myelopathy/tropical spastic paraparesis
( see spastic paralysis )
|
| | human papilloma virus infection
( see human papilloma virus/HPV )
|
| |
human papilloma virus/HPV
|
|
| | human papillomavirus infection
( see human papilloma virus/HPV )
|
| | human T lymphotropic virus type I infection
( see HTLV-1 infection )
|
| |
Huntington's disease
|
|
| | Huntingtons disease
( see Huntington's disease )
|
| | hydrometrocolpos
( see noninflammatory disorders of vagina, other specified )
|
| |
hyper IgE Syndrome
|
|
| | hyperactivity
( see hyperactivity disorder )
|
| |
hyperactivity disorder
|
| | hyperalphalipoproteinemia
( see hyperlipidemia )
|
| |
hyperandrogenism
|
|
| | hyperbilirubinemia
( see jaundice )
|
| |
hypercalciuria
|
| |
hypercholesterolemia
|
|
| | hypercholesterolemia, familial
( see hypercholesterolemia )
|
| |
hypercoagulability
|
|
| |
hyperglycemia
|
|
| | hyperhomocysteinemia
( see homocystinuria )
|
| | hyperhomocystinemia
( see homocystinuria )
|
| |
hyperinsulinemia
|
|
| | Hyperkalemic Periodic Paralysis Type 1
( see familial periodic paralysis )
|
| | hyperkeratosis
( see keratoderma, acquired )
|
| | hyperkinetic disorder
( see hyperactivity disorder )
|
| |
hyperlipidemia
|
|
| | hyperlipidemia, familial combined
( see hyperlipidemia )
|
| |
hyperlipidemia, mixed
|
| | hyperlipoproteinemia
( see hyperlipidemia )
|
|
| | hyperlipoproteinemia, type III
( see hyperlipidemia, mixed )
|
| |
hyperostosis of skull
|
| | Hyperoxaluria
( see carbohydrate metabolism disorders, other )
|
| | hyperoxaluria, primary, type 1
( see carbohydrate metabolism disorders, other )
|
| |
hyperparathyroidism
|
|
| | hyperparathyroidism, primary
( see hyperparathyroidism )
|
| | hyperphenylalaninaemia
( see phenylketonuria/PKU )
|
| |
hyperprothrombinemia
|
| | hypersensitivity vasculitis
( see purpura, allergic )
|
| |
hypersomnolence
|
| |
hypertenion
|
| |
hypertension
|
|
| |
hypertension, cirrhotic portal
|
| | hypertension, gestational
( see hypertension, pregnancy induced )
|
| | hypertension, ocular
( see ocular hypertension )
|
| |
hypertension, pregnancy induced
|
|
| | hypertension, pulmonary
( see pulmonary hypertension )
|
| | hypertension, salt sensitive
( see hypertension )
|
| |
hypertensive heart disease
|
|
| |
hyperthermia, malignant
|
|
| |
hyperthyroidism
|
| |
hypertriglyceridemia
|
|
| | hypertrophic cardiomyopathy
( see cardiomyopathy, hypertrophic )
|
| | hypertrypsinaemia
( see pancreatic disease )
|
| | hypertrypsinemia
( see enzyme levels, abnormal )
|
| |
hypnotizability
|
| | hypoalphalipoproteinemia
( see lipoprotein deficiencies )
|
| | hypochondroplasia
( see chondrodystrophy )
|
| | hypofibrinolysis
( see coagulation disorder )
|
| |
hypoglycemia
|
|
| | hypogonadism
( see hypogonadism, male )
|
| |
hypogonadism, male
|
| | Hypokalemic Periodic Paralysis
( see familial periodic paralysis )
|
| | hypolactasia
( see lactose intolerance )
|
| | hypolactasia, adult-type
( see lactose intolerance )
|
| | hyponatraemia
( see hyponatremia )
|
| |
hyponatremia
|
| |
hypopharyngeal cancer
|
|
| |
hypoplastic left heart syndrome
|
|
| |
hypospadias
|
| | hypotension
( see orthostatic hypotension )
|
| | hypotension, orthostatic
( see orthostatic hypotension )
|
| |
hypothyroidism
|
|
| | hypothyroidism, autoimmune
( see hypothyroidism )
|
| |
hypothyroidism, congenital
|
| | hypoxic brain damage
( see brain damage, hypoxic )
|
| |
| | I | Top |
| |
ibuprofen clearance
|
| |
ichthyosis congenita
|
| | idiopathic pulmonary fibrosis
( see pulmonary fibrosis )
|
| | Idiopathic Scoliosis
( see scoliosis )
|
| | IgA nephropathy
( see nephropathy )
|
| |
IgA, IgD, IgG, IgM
|
| |
IgD
|
| |
IgE
|
| |
IgE levels
|
| |
IgE response
|
| |
IgE response to D.pteronyssinus
|
| |
IGF-I
|
| |
IGF1 levels
|
| |
IgG
|
| |
IgG deficiency
|
| | IgG subclass deficiency
( see IgG deficiency )
|
| |
IGT
|
| |
IL-1 alpha protein
|
| |
IL-1 beta serum levels
|
| |
IL-10
|
| |
IL-1beta
|
| |
IL-1beta protein
|
| |
IL-1RI
|
| |
IL-4
|
| |
IL-6
|
| |
ileitis terminal
|
| | ileitis terminalis
( see ileitis terminal )
|
| | ill health, sheep dip related
( see organophosphate toxicity )
|
| |
immune deficiency
|
|
| |
immune disorder, specified
|
|
| |
immune function
|
| |
immune response
|
| | immune restoration disease
( see autoimmune disorder )
|
| |
immunity deficiency, combined
|
| |
immunodeficiency, hyper-IgM
|
|
| |
immunological findings & UVB
|
| |
impulse control disorder
|
|
| | impulsive behavior
( see impulse control disorder )
|
| | impusivity
( see impulse control disorder )
|
| |
in vitro fertilization success
|
| |
Inclusion body myopathy type 2
|
| | inducibility of CYP2E1 by ethanol
( see alcoholism )
|
| | infant birthweight
( see birth weight )
|
| |
infant development
|
| |
infant mortality
|
| | infection after allogeneic stem cell transplant
( see infection, post allograft )
|
| |
infection, post allograft
|
|
|
| |
infectious disease, unspecified
|
| | infertility
( see infertility, male )
|
| |
infertility, female
|
|
|
| |
infertility, male
|
|
| | infertility, polycystic ovary syndrome related
( see infertility, female )
|
| |
infertility, tubal factor
|
|
| |
inflammation
|
| |
inflammatory bowel disease
|
|
| | inflammatory disease
( see infectious disease, unspecified )
|
| | inflammatory myopathies
( see myopathy, idiopathic inflammatory )
|
| | inflammatory response
( see infectious disease, unspecified )
|
| |
inhibin B levels
|
| | inosine triphosphate deficiency
( see enzyme deficiency )
|
| |
insomnia
|
|
| |
insulin
|
| |
insulin resistance
|
| |
insulin response
|
| |
insulin response, first phase
|
| |
insulin secretion
|
| |
insulin sensitivity
|
| |
insulin therapy, early progression to
|
| |
insulin, fasting immunoreactive
|
| |
insulin-like growth factor
|
| |
insulin-like growth factor-1
|
| |
Insulin-like growth factor-3
|
| | insulitis
( see pancreatic secretion disorders )
|
| |
intelligence
|
| |
interferon response
|
| |
interleukin 6 levels
|
| | interpersonal sensitivity
( see sensitivity, interpersonal )
|
| |
interstitial cystitis
|
|
| |
interstitial nephritis
|
| |
intervertebral disc disease
|
| |
intestinal fatty acid absorption
|
| | intestinal metaplasia
( see metaplasia, intestinal )
|
| |
intima media thickness
|
| |
intima-media thickness
|
| |
intima-media thickness, carotid
|
| | intracerebral hemorrhage
( see brain hemorrhage )
|
| | intracranial hemorrhage
( see hemorrhage, intracranial )
|
| |
intragastric acidity
|
| | intraocular pressure
( see glaucoma )
|
| |
intrauterine death
|
| |
intrauterine growth
|
| |
intrauterine growth restriction
|
| |
intrauterine growth retardation
|
|
| |
intussusception
|
| |
irinotecan pharmacogenetics
|
| |
irinotecan pharmacokinetics
|
| | irinotecan toxicity
( see antineoplastic and immunosuppressive toxicity )
|
| |
irinotecan, renal clearance of
|
| |
iron
|
| |
iron deficiency
|
| |
iron levels
|
| |
iron load
|
| |
iron metabolism
|
| |
iron overload
|
| |
iron stores
|
| |
iron, hepatic
|
| |
irriitable bowel syndrome
|
| | irritable bowel disease
( see irritable bowel syndrome )
|
| |
irritable bowel syndrome
|
|
| | ischemia
( see vascular disease )
|
| | ischemic stroke
( see cerebrovascular disease, ischemic )
|
| |
isoprenaline, response to
|
| |
itai-itai disease
|
|
| |
| | J | Top |
| | Jackson-Weiss syndrome
( see acrocephalosyndactyly )
|
| | Jacob-Creutzfeld disease
( see Jakob-Creutzfeldt disease )
|
| |
Jakob-Creutzfeldt disease
|
|
| |
jaundice
|
|
| |
jaundice, neonatal
|
|
| | Joubert Syndrome
( see congenital malformation syndromes, other )
|
|
| |
juvenile arthritis
|
|
| |
juvenile oligoarthritis
|
| |
juvenile polyposis
|
| | Juvenile polyposis syndrome
( see colon polyps )
|
| |
juvenile rheumatoid arthritis, pauciarticular
|
| |
| | K | Top |
| |
kallikrein activity, urinary
|
| |
Kaposi's sarcoma
|
|
| | Kaposis Sarcoma
( see Kaposi's sarcoma )
|
| |
kawasaki disease
|
|
| |
keloid disease
|
|
| |
keratoderma, acquired
|
| |
keratosis
|
| |
kidney cancer
|
|
| |
kidney disease
|
|
| |
kidney dysfunction
|
|
| |
kidney failure
|
|
| |
kidney failure, chronic
|
|
| |
kidney failure, neonatal acute
|
| |
kidney function
|
| | kidney graft dysfunction
( see kidney transplant complications )
|
| | kidney graft survival
( see kidney transplant complications )
|
| |
kidney stone disease
|
|
| |
kidney transplant
|
| |
kidney transplant complications
|
|
| | kidney transplant rejection
( see kidney transplant complications )
|
| |
kidney transplantation
|
| | Klinefelter Syndrome
( see Klinefelter's syndrome )
|
| |
Klinefelter's syndrome
|
| | Krabbes disease
( see leukodystrophy )
|
| |
kuru
|
|
| |
| | L | Top |
| |
lactase persistence
|
| | lactic acidosis
( see acidosis )
|
| |
lactose intolerance
|
| |
lansoprazole pharmacokinetics
|
| | large granular lymphocyte syndrome
( see lymphoproliferative disorders )
|
| |
laryngeal cancer
|
|
| |
lasoprazole pharmacokinetics
|
| |
late-onset airflow obstruction
|
| |
late-onset congenital adrenal hyperplasia
|
| | latex allergy
( see contact dermatitis, chemical products )
|
| |
lathosterol
|
| |
Le(b) antigen
|
| |
lead
|
| |
lead blood levels
|
| |
lead toxicity
|
|
| | lead toxicity, neurobehavioral
( see lead toxicity )
|
| | Leber congenital amaurosis
( see Leber's amaurosis, congenital )
|
| |
Leber congenital amaurosis/LCA
|
|
| | Leber Hereditary Optic Neuropathy
( see Leber congenital amaurosis/LCA )
|
| |
Leber's amaurosis, congenital
|
| |
left ventricular dysfunction
|
| |
left ventricular function
|
| |
left ventricular hypertrophy
|
|
| | left ventricular hypertrophy, exercise induced
( see left ventricular hypertrophy )
|
| | left ventricular mass
( see left ventricular hypertrophy )
|
| | left ventricular modeling, post myocardial infarction
( see myocardial infarct )
|
| | left ventricular structure
( see left ventricular hypertrophy )
|
| |
Legg-Perthes disease
|
| |
Leigh syndrome
|
| | leiomyoma
( see uterine fibroids )
|
| | leiomyomata
( see uterine fibroids )
|
| |
leishmaniasis
|
| |
leishmaniasis, Mediterranean
|
| |
leprosy
|
|
| |
leprosy, tuberculoid
|
|
| |
leptin
|
| |
leptin concentrations
|
| |
leptin expression
|
| |
leptospirosis
|
| | Lesch-Nyhan Syndrome
( see disorders of purine and pyrimidine metabolism, other )
|
| |
leukemia
|
|
| | leukemia, acute lymphoblastic
( see leukemia, lymphoid )
|
| | leukemia, acute myeloid
( see leukemia, myeloid )
|
| | leukemia, adult acute
( see leukemia )
|
| | leukemia, adult acute lymphocytic
( see leukemia )
|
| | leukemia, adult T cell
( see leukemia, lymphoid )
|
| | leukemia, childhood acute
( see leukemia )
|
| | leukemia, childhood acute lymphoblastic
( see leukemia, lymphoid )
|
| |
leukemia, childhood acute myeloid
|
| | leukemia, chronic lymphocytic
( see leukemia, lymphoid )
|
| |
leukemia, lymphoid
|
|
| | leukemia, myelodysplastic (TRLIMDS)
( see leukemia, myeloid )
|
| |
leukemia, myeloid
|
|
| | leukemia/lymphoma, T-Cell
( see leukemia, lymphoid )
|
| | leukoaraiosis
( see leukoencephalopathy )
|
| |
leukocytes
|
| |
leukodystrophy
|
|
| |
leukoencephalopathy
|
|
| | leukopenia, severe toxicity of
( see agranulocytosis )
|
| | leukoplakia
( see leukoplakia, oral )
|
| |
leukoplakia, oral
|
| |
Lewy body disease
|
| | Li-Fraumeni Syndrome
( see Autosomal deletion syndromes )
|
| |
lichen planus, oral
|
| |
life expectancy
|
| |
limb deficiency defects
|
|
| | Limb-Girdle Muscular Dystrophy
( see muscular dystrophy )
|
| | lipaemia
( see hyperlipidemia )
|
| |
lipid metabolism
|
| |
lipid metabolism disorders
|
|
| |
lipid oxidation
|
| |
lipid peroxidation
|
| |
lipidoses
|
| |
lipids
|
| |
lipodystrophy
|
|
| |
lipolysis
|
| |
lipolysis, chatecholamine-induced
|
| |
lipopolysaccharide hyporesponsiveness
|
| |
lipoprotein
|
| |
lipoprotein deficiencies
|
| |
lipoprotein lipase activity
|
| |
lipoprotein oxidation
|
| |
lipoprotein, LDL
|
| |
lipoproteins
|
| | Lissencephaly
( see Holoprosencephaly )
|
| |
liver cancer
|
|
| | liver disease
( see liver disorder )
|
| | liver disease in chronic hepatitis C
( see liver disorder )
|
| | liver disease, alcholic
( see liver disease, alcoholic )
|
| |
liver disease, alcoholic
|
|
| | liver disease, autoimmune
( see liver disease, nonalcoholic fatty )
|
| |
liver disease, chronic
|
|
| | liver disease, chronic alcoholic
( see liver disease, alcoholic )
|
| |
liver disease, chronic and cirrhosis
|
|
| | liver disease, end-stage
( see liver disorder )
|
| |
liver disease, nonalcoholic fatty
|
|
| |
liver disorder
|
| |
liver disorders in pregnancy
|
| | liver enzymes, methotrexate-related elevation of
( see antineoplastic and immunosuppressive toxicity )
|
| |
liver failure, acute
|
| |
liver function
|
| | liver toxicity
( see adverse effects of anti-Parkinson agents )
|
| |
liver transplant
|
| |
liver transplant complications
|
| | liver transplantation, immunosuppression after
( see immune deficiency )
|
| | lobar hemorrhage
( see brain hemorrhage )
|
| |
Lofgren's syndrome
|
| |
Long QT syndrome
|
|
| | long-QT syndrome
( see Long QT syndrome )
|
| |
longevity
|
| |
loperamide concentration
|
| |
losartan oxidation
|
| |
loudness dependence
|
| |
low back pain
|
| | low birthweight
( see birth weight )
|
| |
Lowe Syndrome
|
|
| |
Lp(a)
|
| |
LpA-I
|
| |
LpA-II
|
| |
LpB
|
| |
LpC-III
|
| |
LpC-III:B lipoprotein particles
|
| |
lpE
|
| |
LpE:B lipoprotein particles
|
| | lumbar disk disease
( see disc disease, lumbar )
|
| | lumbar spine degeneration
( see disc degeneration, lumbar spine )
|
| | lumen loss, late
( see atherosclerosis, coronary )
|
| |
lung cancer
|
|
| | lung cancer, non-small cell
( see lung cancer )
|
| | lung cancer, small cell
( see lung cancer )
|
| |
lung disease
|
|
| |
lung function
|
| |
lung transplant complications
|
|
|
| |
lupus erythematosus
|
|
| | lupus nephritis
( see lupus erythematosus )
|
| | lupus, neuropsychiatric
( see lupus erythematosus )
|
| |
lutein
|
| |
luteinizing homone
|
| |
lycopene
|
| |
lymphocyte count
|
| | lymphoid leukemia
( see leukemia, lymphoid )
|
| |
lymphoma
|
|
| | lymphoma, follicle center
( see lymphoma )
|
| | lymphoma, malignant
( see lymphoma )
|
| | lymphoma, non-Hodgkin
( see lymphoma )
|
| |
lymphoproliferative disorders
|
|
| |
lysosomal storage disorders
|
| |
| | M | Top |
| |
m-chlorophenylpiperazine levels
|
| |
m-chlorophenypiperazine
|
| | Machado-Joseph disease
( see spinocerebellar diseases, other )
|
| | macroangiopathy
( see vascular disease )
|
| |
macular degeneration
|
|
| | macular degeneration, age-related
( see macular degeneration )
|
| | macular degeneration, age-related (AMD)
( see macular degeneration )
|
| |
macular edema
|
|
| |
maculopathy
|
|
| | major depressive disorder
( see depressive disorder, major )
|
| |
malaria
|
|
| | malaria infection
( see malaria )
|
| | malaria morbidity
( see malaria )
|
| | malaria, cerebral
( see malaria )
|
| |
malaria, plasmodium falciparum
|
|
|
| |
malignant hyperthermia
|
| | malignant melanoma
( see melanoma )
|
| | malignant mesothelioma
( see lung cancer )
|
| |
malnutrition
|
| | malnutrition-modulated diabetes
( see malnutrition )
|
| |
mammographic density
|
| |
manganese toxicity
|
| | manganism, susceptibility to occupational chronic
( see manganese toxicity )
|
| |
mania, antidepressant-induced
|
|
| |
manic depression
|
|
| |
mannose-binding lectin insufficiency
|
| |
mannose-binding lectin levels
|
| |
maple syrup urine disease
|
|
| |
Marfan syndrome
|
|
| |
maternal serum alpha-fetoprotein
|
| |
maternally inherited diabetes and deafness
|
| |
maximum calcium, 1,25(OH)2D3
|
| | MCADD (medium chain acyl-coA hydrhydrogenase defin
( see lipid metabolism disorders )
|
| | McAlister Dysplasia
( see musculoskeletal anomalies, other )
|
| |
measles
|
|
| | measles antibody level
( see measles )
|
| | mediterranean visceral leishmaniasis
( see leishmaniasis, Mediterranean )
|
| | medium-chain acyl-CoA dehydrogenase deficiency
( see lipid metabolism disorders )
|
| |
melanoma
|
|
| | melanoma, cutaneous
( see melanoma )
|
| | melanoma, cutaneous malignant
( see melanoma )
|
| | melanoma, sporadic primary
( see melanoma )
|
| | melanoma, uveal
( see melanoma )
|
| | MELAS
( see chromosomal anomalies )
|
| |
MELAS syndrome
|
| |
melatonin production
|
| | memory decline
( see memory disturbance )
|
| |
memory disturbance
|
|
| | memory impairment
( see memory disturbance )
|
| | memory impairment, subjective
( see memory disturbance )
|
| | memory performance
( see memory disturbance )
|
| |
menarche
|
|
| |
Meniere's disease
|
|
| |
meningioma
|
| |
meningococcal disease
|
|
| | Menkes Syndrome
( see congenital malformation syndromes, other )
|
| |
mennose-binding lectin deficiency
|
| |
menopause
|
|
| | menopause, early
( see premature ovarian failure )
|
| |
mental disorder
|
|
| |
mental retardation
|
| |
menthol
|
| |
mephobarbital metabolism
|
| |
mercury neurotoxicity
|
| |
metabolic rate, resting
|
| |
metabolic syndrome
|
| |
metabolism
|
| |
metabolism disorders
|
|
|
| |
metabolism of N,N-dimethylformamide
|
| |
metabolism of nortiptyline
|
| |
metabolites of lansoprazole
|
| |
metabolites of omerprazole
|
| |
metabolites of sodium rabeprazole
|
| | metamphetamine dependence
( see methamphetamine dependence )
|
| |
metaplasia, intestinal
|
|
| |
methadone toxicity
|
| |
methadone treatment outcome
|
| |
methamphetamine abuse
|
|
| |
methamphetamine dependence
|
| |
methemoglobinemia
|
| | Methemoglobinemia, beta-globin type
( see methemoglobinemia )
|
| |
methionine
|
| |
methotrexate levels
|
| | methotrexate toxicity
( see antineoplastic and immunosuppressive toxicity )
|
| | methotrexate toxicity in rheumatoid arthritis treatment
( see rheumatoid arthritis )
|
| |
methylation status of p16 tumor suppresor gene and MGMT
|
| | metoprolol associated adverse effects
( see adverse effects of sympatholytics )
|
| |
metoprolol metabolism
|
| |
metoprolol pharmacokinetics
|
| | mevalonate kinase deficiency
( see enzyme deficiency )
|
| | microalbuminuria
( see albuminuria )
|
| | microalbuminuria, diabetic
( see albuminuria )
|
| |
microalbuniuria
|
| | microangiopathy
( see peripheral vascular disease )
|
| | microangiopathy, diabetic
( see angiopathy, diabetic )
|
| |
microangiopathy, thrombotic
|
|
| | microangiopathy-related cerebral damage
( see peripheral vascular disease )
|
| |
microglia
|
| |
micronuclei frequency
|
| |
micropenis
|
|
| | Microphthalmia
( see microphthalmos )
|
| |
microphthalmos
|
| |
microscopic polyangiitis
|
| |
microsomal protein
|
| | microvascular basement membrane injury
( see cerebral arteriopathy )
|
| | microvascular complications
( see vascular disease )
|
| | microvascular dermatoses, diabetes-associated
( see diabetes )
|
| |
microvascular function
|
| |
midazolam clearance
|
| |
midazolam level
|
| |
midazolam pharmacokinetics
|
| |
migraine
|
|
| |
migraine with aura
|
|
| |
migraine, hemiplegic
|
|
| |
mild head injury
|
| |
minimal change nephrotic syndrome
|
| |
mitochondrial disorders
|
| |
mitochondrial encephalomyopathy
|
| |
mitochondrial myopathy
|
| |
mitral annular calcification
|
| |
mitral valve prolapse
|
|
| | mixed connective tissue disease
( see connective tissue disease, mixed )
|
| |
mixed polyneuropathy
|
| |
MMP9
|
| | MODY
( see diabetes, type 2 )
|
| |
monoamine metabolite concentrations
|
| |
monoamine metabolites
|
| | mood disorder
( see affective psychoses )
|
| |
mood response
|
| |
morphine glucuronidation
|
| |
mortality
|
| |
mortality in critically ill patients
|
| |
mortality risk
|
| |
motion sickness
|
|
| |
motor neuron disease
|
|
| |
Moyamoya disease
|
| | mucolipidosis
( see lipidoses )
|
| |
mucopolysaccharidosis
|
| |
mucopolysaccharidosis I
|
| | Mucopolysaccharidosis Type I
( see mucopolysaccharidosis )
|
| | Muenke syndrome
( see craniosynostosis )
|
| |
multiple chemical sensitivity
|
| |
multiple endocrine neoplasia
|
| |
multiple epiphyseal dysplasia
|
|
| | Multiple hamartoma syndrome
( see hamartomas )
|
| | multiple infarction dementia
( see dementia, arteriosclerotic )
|
| |
multiple myeloma
|
|
| |
multiple pregnancy
|
|
| |
multiple sclerosis
|
|
| | multiple sclerosis, juvenile
( see multiple sclerosis )
|
| | multiple system atrophy
( see extrapyramidal disease/abnormal movement disorder )
|
| |
muscle response
|
| |
muscle strength
|
| |
muscle testing
|
| |
muscular dystrophy
|
|
| |
muscular dystrophy, congenital hereditary
|
| | Muscular Dystrophy, oculopharyngeal
( see muscular dystrophy )
|
| |
musculoskeletal anomalies, other
|
| |
mutagen sensitivity
|
| |
mutagenicity, urinary
|
| |
myasthenia gravis
|
|
| | mycobacteria
( see mycobacteria, diseases due to )
|
| |
mycobacteria, diseases due to
|
| | Mycobacterium avium complex
( see pulmonary disease, Mycobacterium )
|
| | Mycobacterium infection
( see mycobacteria, diseases due to )
|
| |
mycoplasma infections
|
| |
myelodysplasia
|
|
| | myelodysplastic syndrome
( see lymphoproliferative disorders )
|
| | myeloma, multiple
( see multiple myeloma )
|
| | myelopathy, HTLV-1 associated
( see HTLV-1 infection )
|
| |
myeloperoxidase activity
|
| |
myeloproliferative disorders
|
| |
myocardial dysfunction, non-ischaemic
|
|
| |
myocardial infarct
|
|
| | myocardial infarction
( see myocardial infarct )
|
| | myocardial injury
( see cardiac bypass surgery complications )
|
| | myocardial ischemia
( see heart disease, ischemic )
|
| |
myoclonus
|
|
| |
myopathy, idiopathic inflammatory
|
|
| |
myopia
|
|
| |
myositis, sporadic inclusion-body
|
| |
myotonic dystrophy
|
|
|
| | myotonic dystrophy type 1
( see myotonic dystrophy )
|
| |
myxedema
|
| |
| | N | Top |
| |
N-(2,3,4-trihydroxybutyl)-valine adducts
|
| |
N-acetyl-S-(3,4-hydroxybutyl)-L-cysteine
|
| |
N-methylformamide, urinary
|
| |
Na/K ATPase activity
|
| |
NADPH Oxidase
|
| |
narcolepsy
|
|
| | narcolepsy-cataplexy symptoms
( see narcolepsy )
|
| |
nasal polyp
|
| | nasal polyposis
( see nasal polyp )
|
| |
nasopharyngeal cancer
|
|
| | nasopharyngeal carcinoma
( see nasopharyngeal cancer )
|
| |
NAT1 enzyme kinetics
|
| |
nausea
|
|
| |
nausea and vomiting
|
| |
necrosis, avascular
|
|
| |
necrotizing enterocolitis
|
|
| |
negative affect
|
| |
Nemaline body disease
|
| | nemaline myopathy
( see Nemaline body disease )
|
| |
neonatal morbidity
|
| | nephritis
( see nephropathy )
|
| | nephritis, Henoch-Schonlein
( see purpura, allergic )
|
| | nephritis, lupus
( see lupus erythematosus )
|
| |
nephrogenic diabetes insipidus
|
|
| |
nephrolithiasis
|
| |
nephropathy
|
|
| |
nephropathy in other diseases
|
|
| |
nephropathy, basement membrane
|
| | nephropathy, diabetic
( see diabetic nephropathy )
|
| | nephropathy, IgA
( see nephropathy )
|
| |
nephrosis
|
| |
nephrotic syndrome
|
|
| | nephrotic syndrome, idiopathic
( see nephrotic syndrome )
|
| |
nervous system activity
|
| |
nervous system disorders, other
|
| |
neural tube defects
|
|
| | neuritis, optic
( see optic neuritis )
|
| | neurocognitive decline
( see memory disturbance )
|
| | neurodegenerative disease
( see nervous system disorders, other )
|
| |
neurofibrillary tangle distribution
|
| | Neurofibromatosis 2
( see neurofibromatosis2 )
|
| |
neurofibromatosis1
|
|
| |
neurofibromatosis2
|
|
| |
neurogenic tumors, childhood
|
| |
neuroleptic malignant syndrome
|
|
| |
neuropathy
|
|
| | neuropathy, Alzheimer's disease related
( see Alzheimer's disease )
|
| | neuropathy, Charcot-Marie-Tooth
( see neuropathy )
|
| | neuropathy, diabetic
( see diabetes, neurological manifestations )
|
| |
neuropathy, non-arteritic ischaemic optic
|
|
| |
neuropsychiatric disorders
|
| |
neuroticism
|
|
| |
neutropenia
|
| | neutropenia, nonimmune chronic idiopathic
( see agranulocytosis )
|
| |
nevi
|
| | nevi, total
( see nevi )
|
| | nevus
( see nevi )
|
| |
nicotine
|
| |
nicotine amounts inhaled per day
|
| | nicotine dependence
( see tobacco use disorder )
|
| |
nicotine metabolism
|
| | Niemann-Pick Disease
( see lipidoses )
|
| |
nifedipine disposition
|
| | Nijmegen Breakage Syndrome
( see spinocerebellar diseases, other )
|
| |
nitirc oxide production
|
| |
nitric oxide
|
| |
nitric oxide activity
|
| |
nitric oxide production
|
| |
nitric oxide, exhaled
|
| |
nitric oxide-mediated effect on resistance vessels
|
| |
NNAL-glucuronidating activities
|
| | nocturnal cough
( see cough )
|
| | non insulin dependent diabetes mellitus
( see diabetes, type 2 )
|
| |
non-apo B-containing lipoproteins
|
| | non-Hodgkin's lymphoma
( see lymphoma )
|
| |
non-secretor status
|
| |
nonarteritic anterior ischemic optic neuropathy
|
| | nondisjunction
( see chromosomal anomalies )
|
| |
nonesterified fatty acid levels
|
| |
noninflammatory disorders of vagina, other specified
|
| |
nonrheumatic atrial fibrillation
|
| |
nonsteroidal anti-inflammatory response
|
| |
nontuberculous mycobacterial infection
|
| | Noonan syndrome
( see congenital malformation syndromes, other )
|
| |
noradrenaline
|
| |
Norrie disease
|
|
| |
nortriptyline
|
| |
nortriptyline clearance
|
| |
nortriptyline concentration
|
| |
novelty seeking
|
| | nut allergy
( see allergy, food )
|
| |
| | O | Top |
| |
obesity
|
|
| |
obesity, localized
|
|
|
| | obesity, visceral
( see obesity, localized )
|
| |
obsessive compulsive disorder
|
|
| | obsessive-compulsive disorder
( see obsessive compulsive disorder )
|
| | obstructive sleep apnea syndrome
( see sleep apnea )
|
| |
occlusion, renal vein, central
|
| |
ocular hypertension
|
|
| |
ocular hystoplasmosis syndrome
|
| | ocular melanoma
( see eye cancer )
|
| |
ocular thromboses
|
| | Oculocutaneous Albinism Type 1
( see aromatic amino acid disturbances )
|
| | Oculopharyngeal Muscular Dystrophy
( see muscular dystrophy )
|
| |
odor identification
|
| | oligoarthritis, juvenile
( see juvenile rheumatoid arthritis, pauciarticular )
|
| | oligoasthenospermia
( see azoospermia )
|
| |
oligospermia
|
|
| | oligozoospermia
( see oligospermia )
|
| |
omeprazole metabolism
|
| |
onchocerciasis
|
|
| |
oocyte quality in IVF
|
| |
ophthalmia, sympathetic
|
| | opiate abuse
( see heroin abuse )
|
| |
opiate toxicity, other
|
| |
opioid abuse
|
| | opioid dependence
( see heroin addiction )
|
| |
opium abuse
|
| | oppositional defiant disorder
( see oppositional disorder )
|
| |
oppositional disorder
|
| |
optic atrophy
|
| |
optic neuritis
|
| |
oral cancer
|
|
| |
oral clefts
|
|
| | oral lichen planus
( see lichen planus, oral )
|
| | oral squamous cell cancer
( see oral cancer )
|
| |
oral submucous fibrosis
|
|
| | Oral-Facial-Digital Syndrome Type I
( see congenital malformation syndromes, other )
|
| | organ damage
( see atherosclerosis, generalized )
|
| |
organic acid disorder
|
|
| |
organic psychosis
|
| |
organophosphate toxicity
|
|
| | orolaryngeal cancer
( see oral cancer )
|
| | oropharyngeal carcinoma
( see oropharynx cancer )
|
| | oropharyngolaryngeal cancers
( see cancers of the lip, oral cavity, and pharynx )
|
| |
oropharynx cancer
|
|
| |
orthostatic hypotension
|
| |
ossification of spine
|
|
| | ossification of the posterior longitudinal ligament
( see ossification of spine )
|
| |
osteoarthritis
|
|
| | osteoarthrosis
( see osteoarthritis )
|
| | osteoarticular complications
( see arthropathy with other bacterial diseases )
|
| |
osteocalcin
|
| |
osteocalcin, circulating
|
| |
osteogenesis imperfecta
|
| |
osteolysis
|
| |
osteomalacia
|
| | osteomyelitis
( see osteomyelitis, unspecified )
|
| |
osteomyelitis, unspecified
|
| |
osteonecrosis
|
|
| |
osteopenia
|
| |
osteoporosis
|
|
| |
osteoporosis, postmenopausal
|
|
| |
osteoporotic fractures
|
|
| |
otitis media
|
|
| |
otosclerosis
|
| | ototoxicity
( see ear disorders )
|
| | outcome after severe injury
( see trauma complications )
|
| | ovarian
( see ovarian cancer )
|
| |
ovarian cancer
|
|
| | overanticoagulation, warfarin therapy-related
( see hemorrhage )
|
| |
ovulatory dysfunctions
|
|
| |
oxazepam glucuronidation
|
| |
oxidative stress
|
| | oxycodone toxicity
( see opiate toxicity, other )
|
| |
oxygen consumption
|
| |
oxygen saturation, arterial
|
| |
| | P | Top |
| |
P-glycoprotein
|
| |
P-glycoprotein expression, placental
|
| |
P-glycoprotein substrate loperamide
|
| |
P-selectin
|
| |
P. aeruginosa infection
|
| |
P300 event-related potentials
|
| |
p53 expression in tumors
|
| |
p53 protein
|
| |
p53-protein accumulation
|
| |
Paget's disease
|
| |
Paget's disease of bone
|
| |
PAH metabolites, urinary
|
| |
PAH-DNA adducts
|
| |
PAI-1 levels
|
| |
pain response
|
| |
palindromic rheumatism
|
|
| | Pallister-Hall Syndrome
( see congenital malformation syndromes, other )
|
| | palmoplantar pustulosis
( see psoriasis )
|
| |
panbronchiolitis
|
| |
pancreatic cancer
|
|
| |
pancreatic disease
|
| |
pancreatic secretion disorders
|
| |
pancreatitis
|
|
| | pancreatitis, acute
( see pancreatitis )
|
| | pancreatitis, alcoholic
( see alcoholism )
|
| | pancreatitis, autoimmune
( see pancreatitis )
|
| |
pancreatitis, chronic
|
|
| | pancreatitis, chronic calcifying
( see pancreatitis, chronic )
|
| | pancreatitis, tropical calcific
( see pancreatitis, chronic )
|
| |
panencephalitis, subacute sclerosing
|
|
| |
panencephalitis, subacute sclerosing
|
| |
panic disorder
|
|
| | Pantothenate Kinase-Associated Neurodegeneration
( see progressive supranuclear palsy )
|
| | paradoxical embolism
( see atherothrombosis )
|
| |
paragangliomas, head and neck
|
|
| |
paranoid ideation
|
|
| |
paraoxonase
|
| |
paraoxonase activity
|
| |
paraoxonase-1
|
| |
paraoxonase1 activity
|
| |
parathyroid
|
| |
parathyroid hormone
|
| |
parathyroid responsiveness
|
| |
parity
|
| |
Parkinson's disease
|
|
| |
parkinsonism
|
| | Parkinsons disease
( see Parkinson's disease )
|
| |
paroxetine concentration
|
| | paroxysmal nocturnal hemoglobinuria
( see hemolytic anemias, acquired )
|
| |
pars planitis
|
| |
parvovirus
|
| |
patent ductus arteriosus
|
| |
pathologic gambling
|
| |
PC-1 protein content
|
| | Pelizaeus-Merzbacher Disease
( see leukodystrophy )
|
| |
pelvic inflammatory disease
|
| | pemphigoid, bullous
( see bullous pemphigoid )
|
| |
pemphigoid, mucous membrane
|
|
| |
pemphigus
|
|
| | pemphigus foliaceus
( see pemphigus )
|
| | pemphigus vulgaris
( see pemphigus )
|
| | Pendred Syndrome
( see hypothyroidism, congenital )
|
| |
peptic ulcer
|
| |
percutaneous transluminal coronary angioplasty
|
| |
perhexiline toxicity
|
| | perinatal transmission of HIV
( see perinatal transmission of infections )
|
| |
perinatal transmission of infections
|
| |
periodic paralysis
|
| |
periodontal disease
|
|
| |
periodontitis
|
|
| | periodontitis, early-onset
( see periodontitis )
|
| | periorbital angiodema
( see angiodema )
|
| | peripheral arterial disease
( see peripheral vascular disease )
|
| |
peripheral vascular disease
|
|
| |
periportal fibrosis
|
| |
peritoneal adhesions
|
|
| |
peritoneal cancer
|
|
| |
peritoneal permeability
|
| |
persistent foramen ovale
|
|
| |
persistent vegetative state
|
|
| |
personality disorders
|
|
| |
personality trait of spritual acceptance
|
| |
personality trait, 'Novelty Seeking'
|
| |
personality traits
|
| |
pesticide toxicity
|
|
| |
Peutz-Jeghers syndrome
|
|
| |
peyronie's disease
|
|
| | Pfeiffer Syndrome
( see acrocephalosyndactyly )
|
| | phenylalanine hydroxylase deficiency
( see phenylketonuria/PKU )
|
| | phenylketonuria
( see phenylketonuria/PKU )
|
| |
phenylketonuria/PKU
|
|
| |
phenytoin
|
| |
phenytoin levels
|
| |
phenytoin metabolism
|
| |
pheochromocytoma
|
|
| |
pheochromocytomas
|
| |
phobia
|
|
| |
phospholipids
|
| |
physical activity
|
| |
physical activity level
|
| |
physical endurance
|
| |
physical performance
|
| |
Pick's disease
|
| | Picks Disease
( see Pick's disease )
|
| |
Pigeon breeders disease
|
|
| |
pigmentary anomalies, congenital
|
| |
pigmentation
|
| |
pituitary cancer
|
|
| | Pituitary hormone deficiency
( see anterior pituitary disorders, other )
|
| | placental abruption
( see abruptio placentae )
|
| |
placental malaria
|
| |
placental vascular complications
|
| | plaque calcification
( see atherosclerosis )
|
| | plaques, asbestosis and/or pleural
( see asbestosis or pleural plaques )
|
| |
plasma fluvoxamine
|
| |
plasminogen activator
|
| |
plasminogen activator inhibitor-1
|
| |
plasminogen activator inhibitor-type 1
|
| | Plasmodium falciparum infection
( see malaria, plasmodium falciparum )
|
| |
platelet aggregability
|
| |
platelet aggregation
|
| |
platelet alpha(2)beta(1), densities of
|
| |
platelet count
|
| |
platelet hyperreactivity
|
| |
platelet thrombogenicity
|
| |
pneumococcal disease
|
| | pneumococcal infection
( see pneumonia )
|
| |
pneumoconiosis, coal workers'
|
|
| | pneumocystis carinii pneumonia
( see pneumocystosis )
|
| |
pneumocystosis
|
| |
pneumonia
|
|
| | pneumonia due to SARS-associated coronavirus
( see SARS (severe acute respiratory syndrome) )
|
| | pneumonia, community-acquired
( see pneumonia )
|
| |
pneumonia, pneumococcal
|
| |
poliomyelitis
|
|
| |
polyarthritis
|
|
| |
polycyclic aromatic hydrocarbons
|
| |
polycyclic aromatic hydrocarbons metabolism
|
| |
polycystic kidney disease
|
|
| |
polycystic kidney disease, autosomal dominant
|
| |
polycystic kidney disease, autosomal recessive
|
| | Polycystic Lipomembranous Osteodysplasia with Scle
( see frontal lobe disorder )
|
| | polycystic ovarian syndrome
( see polycystic ovary syndrome )
|
| |
polycystic ovary syndrome
|
|
| |
polycythemia
|
| |
polycythemia vera
|
|
| |
polydactyly
|
| |
polydipsia
|
|
| | polyendocrinopathy-candidiasis-ectodermal dystrophy, autoimmune
( see polyglandular dysfunction )
|
| |
polyglandular dysfunction
|
| |
polyglandular dysfunction, other
|
| | polymetabolic syndrome
( see metabolism disorders )
|
| | polymorphic light eruption
( see solar radiation dermatitis )
|
| |
polymyalgia rheumatica
|
|
| |
polymyositis
|
|
| |
polyneuropathy
|
|
| | polyposis, duodenal
( see duodenal polyps )
|
| | polyposis, gastric
( see gastric polyps )
|
| | polyposis, juvenile
( see colon polyps )
|
| |
poor metabolizer status
|
| |
porencephaly
|
| |
porphyria
|
|
| | porphyria cutanea tarda
( see porphyria )
|
| | porphyria, acute intermittent (AIP)
( see porphyria )
|
| |
portal vein thrombosis
|
| |
post myocardial infarction complications
|
|
| | post-renal transplant diabetes
( see kidney transplant complications )
|
| |
post-transplant erythrocysosis
|
| |
post-traumatic stress disorder
|
|
| | postaxial polydactyly
( see polydactyly )
|
| |
postherpetic neuralgia
|
|
| |
postpartum depression
|
| |
posttransplantation erythrocytosis
|
| |
potassium
|
| |
pouchitis
|
| | pouchitis after ileal pouch-anal anastomosis formation
( see colostomy or enterostomy infection )
|
| |
Prader-Willi syndrome
|
|
| |
pravastatin kinetics
|
| | precocious pubarche
( see precocious puberty )
|
| |
precocious puberty
|
|
| |
preeclampsia
|
|
| |
prefrontal activity
|
| |
pregnancy complications
|
|
| |
pregnancy loss
|
| |
pregnancy loss, recurrent
|
|
| | premature delivery
( see preterm delivery )
|
| |
premature ovarian failure
|
|
| | premature pubarche
( see precocious puberty )
|
| |
premature rupture of membranes
|
|
| | premenstrual dysphoric disorder
( see depression )
|
| |
premenstrual syndrome
|
| |
prenatal viability
|
| |
presumed ocular histoplasmosis syndrome
|
| |
preterm delivery
|
|
| |
preterm labor
|
|
| | primary antiphospholipid syndrome
( see antiphospholipid syndrome )
|
| | Primary Hyperoxaluria Type 1
( see carbohydrate metabolism disorders, other )
|
| | primary idiopathic myxedema
( see myxedema )
|
| | Primary Pulmonary Hypertension
( see pulmonary hypertension )
|
| |
progesterone
|
| |
progressive muscular atrophy
|
| |
progressive supranuclear palsy
|
|
| |
proinflammatory cytokine expression
|
| |
proinsulin
|
| |
prolactin
|
| |
prolactin, lymphocyte
|
| |
prolonged mechanical ventilation
|
|
| |
propafenone metabolism
|
| |
prostate cancer
|
|
| | prostate enlargement
( see prostatic hyperplasia )
|
| |
prostate specific antigen
|
| |
prostate volume/histology endocrine patterns
|
| |
prostate-specific antigen levels
|
| |
prostatic hyperplasia
|
|
| |
prostatitis
|
|
| |
protein C
|
| |
protein excretion, urinary
|
| |
protein fraction levels
|
| |
protein S
|
| | proteinuria
( see albuminuria )
|
| |
prothrombin
|
| | Pseudo-Gaucher disease
( see lipidoses )
|
| |
pseudoachondroplasia
|
| | pseudohypoparathyroidism
( see chondrocalcinosis )
|
| | Pseudomonas aeruginosa infection
( see pseudomonas infection )
|
| |
pseudomonas infection
|
| | Pseudoxanthoma Elasticum
( see Epidermolysis bullosa )
|
| |
psoriasis
|
|
| | psoriasis vulgaris
( see psoriasis )
|
| |
psoriatic arthritis
|
|
| | psychiatric disease
( see psychoticism )
|
| | psychiatric disorders
( see mental disorder )
|
| | psychiatric symptomatology in Alzheimer's disease
( see organic psychosis )
|
| | psychiatric symptoms
( see mental disorder )
|
| |
psychological response to genetic testing
|
| |
psychoses
|
|
| | psychoses, major
( see psychoses )
|
| | psychosis
( see psychoticism )
|
| |
psychosis, alcoholic
|
|
| | psychosis, Alzheimer's disease related
( see psychosis, organic, chronic )
|
| |
psychosis, organic, chronic
|
| |
psychosis, puerperal
|
|
| |
psychosocial behavior
|
| | psychotic symptoms
( see dementia in other conditions )
|
| |
psychoticism
|
|
| |
pterygium
|
| |
PTH
|
| | puberty onset
( see menarche )
|
| |
pulmonary disease, Mycobacterium
|
| | pulmonary disease, Mycobacterium malmoense
( see pulmonary disease, Mycobacterium )
|
| |
pulmonary edema
|
|
| | pulmonary embolism
( see pulmonary thromboembolism )
|
| |
pulmonary fibrosis
|
|
| |
pulmonary function
|
| |
pulmonary hypertension
|
|
| |
pulmonary thromboembolism
|
|
| |
pulse pressure
|
| |
purpura, allergic
|
|
| | purpura, Henoch-Schonlein
( see purpura, allergic )
|
| | purpura, idiopathic thrombocytopenic
( see thrombocytopenic purpura, idiopathic )
|
| | Puumala hantavirus infection
( see hantavirus )
|
| |
pyelonephritis
|
|
| |
pyridinoline, urinary
|
| |
| | Q | Top |
| |
Q fever
|
|
| | QT dispersion
( see Long QT syndrome )
|
| | QT dispersion after myocardial infarction
( see myocardial infarct )
|
| |
QT interval
|
| |
quality of life
|
| |
quantitative calcaneal ultrasounds
|
| |
| | R | Top |
| | radiation, UV, sensitivity to
( see UV, sensitivity to )
|
| |
radiosensitivity
|
| |
radiotherapy response
|
| |
radiotherapy sensitivity
|
| |
RANTES production
|
| | rapid cycling mood disorder
( see affective psychoses )
|
| |
rectal cancer
|
|
| |
rectal GST enzyme activity
|
| | recurrent aphthous stomatitis
( see aphthous stomatitis, recurrent )
|
| | recurrent cardiovascular event
( see cardiovascular event, recurrent )
|
| | recurrent pregnancy loss
( see pregnancy loss, recurrent )
|
| | recurrent respiratory papillomatosis
( see respiratory papillomatosis )
|
| |
Refsum's disease
|
| | Refsums disease
( see Refsum's disease )
|
| |
renal ACE mRNA quantification
|
| |
renal allograft function
|
| |
renal allograft outcome
|
| | renal allograft rejection
( see kidney transplant complications )
|
| | renal artery disease
( see arterial disease )
|
| | renal cancer
( see kidney cancer )
|
| | renal cell carcinoma
( see kidney cancer )
|
| | renal disease
( see kidney disease )
|
| | renal disease, end stage
( see kidney failure, chronic )
|
| | renal disease, end-stage
( see kidney failure, chronic )
|
| | renal dysfunction
( see kidney dysfunction )
|
| | renal dysfunction, heart transplant related
( see kidney dysfunction )
|
| | renal dysfunction, posttransplantation
( see kidney dysfunction )
|
| | renal failure, chronic
( see kidney failure, chronic )
|
| | renal failure, neonatal acute
( see kidney failure, neonatal acute )
|
| |
renal function
|
| |
renal graft function
|
| |
renal perfusion
|
| |
renal plasma flow
|
| | renal scarring, vesico-ureteric reflux related
( see vesicoureteral reflux )
|
| |
renal sodium handling
|
| |
renal transplant
|
| | renal transplant outcome
( see kidney transplant complications )
|
| | renal transplantation, disease progression after
( see kidney dysfunction )
|
| |
renal transplantation, protein secretion in
|
| | renal transplantation, rejection after
( see kidney transplant complications )
|
| |
renal-transplant survival
|
| |
renin activity
|
| |
renin-angiotensin system parameters
|
| |
repaglinide pharmacology
|
| |
resistin
|
| |
respiratory airway resistance
|
| |
respiratory disease
|
| | respiratory distress syndrome
( see respiratory distress syndrome, neonatal )
|
| | respiratory distress syndrome, acute
( see respiratory distress syndrome, neonatal )
|
| |
respiratory distress syndrome, neonatal
|
|
| | respiratory illness
( see respiratory disease )
|
| |
respiratory papillomatosis
|
| |
respiratory papillomatosis, juvenile-onset recurrent
|
| |
respiratory syncytial virus
|
|
| | respiratory syncytial virus infection
( see respiratory syncytial virus )
|
| |
respiratory tract infection
|
| |
response to cannabis
|
| |
response to HAART
|
| | restenosis
( see atherosclerosis, coronary )
|
| | restenosis, angiographic
( see atherosclerosis, coronary )
|
| | restenosis, coronary stent
( see atherosclerosis, coronary )
|
| |
restless legs
|
| | restless legs syndrome
( see restless legs )
|
| | retinal artery occlusion
( see retinal vascular occlusion )
|
| |
retinal disease
|
| |
retinal dystrophy
|
|
| |
retinal function
|
| |
retinal vascular occlusion
|
|
| | retinal vascular occlusive disease
( see retinal vascular occlusion )
|
| |
retinal vasculitis
|
| | retinal vein occlusion
( see retinal vascular occlusion )
|
| |
retinitis pigmentosa
|
|
| |
retinoblastoma
|
|
| |
retinol
|
| |
retinopathy
|
|
| |
retinopathy of prematurity
|
|
| | retinopathy, diabetic
( see diabetes, ophthalmic manifestations )
|
|
|
| |
Rett syndrome
|
|
| |
revascularization, coronary
|
| |
revascularization, urgent
|
| |
Rh incompatibility
|
| | RhD-negative sensitized pregnancy
( see Rh incompatibility )
|
| |
Rheiter's syndrome
|
| |
rheumatic arthritis
|
| |
rheumatic fever
|
| |
rheumatic heart disease
|
|
| |
rheumatoid arthritis
|
|
| |
rhinitis
|
|
| | rhinitis, allergic
( see allergic rhinitis )
|
| | rhinoconjunctivitis
( see rhinitis )
|
| |
riboflavin status
|
| |
rickets
|
|
| | rickets, susceptibility to developing
( see rickets )
|
| |
risperidone
|
| | Rogers Syndrome
( see anemia, megaloblastic, other )
|
| | Rothmund-Thomson Syndrome
( see pigmentary anomalies, congenital )
|
| | Russell-Silver Syndrome
( see congenital malformation syndromes, other )
|
| |
| | S | Top |
| |
S-phenymercapturic acid excretion, rate of
|
| |
S/R-mephenytoin
|
| |
sacroiliitis
|
|
| | SADDAN
( see congenital malformation syndromes, other )
|
| |
salt sensitivity
|
| | Sandhoff disease
( see Tay-Sachs disease )
|
| |
Sanhoff disease
|
| |
sarcoidosis
|
|
| | sarcoidosis pulmonary disease
( see sarcoidosis )
|
| | sarcoidosis-associated erythema nodosum
( see sarcoidosis )
|
| |
sarcopenia
|
|
| |
SARS (severe acute respiratory syndrome)
|
|
| |
schistosomiasis
|
|
| |
schizoaffective disorder
|
|
| | schizoid traits
( see schizotypal personality )
|
| |
schizophrenia
|
|
| |
schizophrenic disorders
|
| |
schizotypal personality
|
| | schizotypy
( see schizotypal personality )
|
| |
sciatica
|
|
| | scleroderma
( see sclerosis, systemic )
|
| | sclerosis, hippocampal
( see white matter disease )
|
| |
sclerosis, systemic
|
|
| |
scoliosis
|
|
| | seasonal affective disorder
( see affective disorder )
|
| |
SECIS function
|
| |
seizures
|
|
| | seizures, alcohol withdrawal-induced
( see seizures )
|
| |
seizures, febrile
|
|
| |
selenium
|
| |
self-harm behavior
|
| |
semen parameters
|
| |
senile plaques
|
| |
sensation seeking
|
| |
sensitivity, interpersonal
|
| | sensitization to house dust mite
( see dust mite, sensitization to )
|
| | sensorineural hearing loss
( see hearing loss, sensorineural nonsyndromic )
|
| |
sepsis
|
|
| |
septic shock
|
|
| |
seronegative spondarthritis
|
| |
serotonergic function
|
| |
serotonin
|
| |
serotonin transporter protein
|
| |
serum tumor necrosis factor-alpha levels
|
| |
severe acute respiratory syndrome
|
| | Severe Combined Immunodeficiency
( see immunity deficiency, combined )
|
| |
sex hormones
|
| |
sex horomone binding globulin
|
| |
sex ratio
|
| |
sex steroid
|
| |
short stature
|
| | shortened gestation
( see preterm delivery )
|
| |
shyness
|
| |
Sickle cell anemia
|
|
| |
SIDS/sudden infant death syndrome
|
|
| | silent myocardial infarction
( see myocardial infarct )
|
| |
silicosis
|
|
| | simvastatin treatment, efficacy and tolerability
( see antilipemic toxicity )
|
| |
sinusitis
|
|
| | Sipples syndrome
( see thyroid cancer )
|
| | sister-chromatid exchanges
( see chromosomal anomalies )
|
| |
Sjogren's syndrome
|
|
| | Sjogren's syndrome, primary
( see Sjogren's syndrome )
|
| | Sjogren's syndrome, secondary
( see Sjogren's syndrome )
|
| | Skeleton-skin-brain syndrome
( see congenital malformation syndromes, other )
|
| | skin cancer
( see skin cancer, non-melanoma )
|
| |
skin cancer, non-melanoma
|
|
| | skin cancer, nonmelanoma
( see skin cancer, non-melanoma )
|
| |
sleep apnea
|
|
| |
sleep disorders
|
|
| | Sleep-disordered breathing
( see sleep apnea )
|
| |
sleepwalking
|
|
| | slow wave sleep
( see sleep disorders )
|
| | small for gestational age
( see fetal growth, poor )
|
| | small-vessel disease
( see peripheral vascular disease )
|
| | Smith-Lemli-Opitz Syndrome
( see congenital malformation syndromes, other )
|
| | Smith-Magenis Syndrome
( see chromosomal anomalies )
|
| |
smoking behavior
|
| |
smoking cessation
|
| | smoking dependence
( see tobacco use disorder )
|
| |
smoking initiation
|
| |
smoking, likelihood of
|
| |
SN-38 pharmacokinetics
|
| | Sneddon syndrome
( see antiphospholipid syndrome )
|
| |
sodium hemostatis
|
| |
sodium transport rate, erythrocyte
|
| |
soft tissue sarcoma
|
| | solar keratosis
( see keratosis )
|
| | solar lentigines
( see freckles and solar lentigines )
|
| |
solar radiation dermatitis
|
| |
soluble IL-6 receptor
|
| |
Sotos syndrome
|
| |
sparteine metabolic ratio
|
| |
spastic paralysis
|
|
|
| |
sperm morphology
|
| |
spermatogenesis
|
| | spina bifida
( see neural tube defects )
|
| | spinal bulbar muscular atrophy
( see spinal muscular atrophy )
|
| |
spinal muscular atrophy
|
|
| |
spinal ossification
|
|
| |
spinocerebellar ataxia
|
|
| | spinocerebellar ataxia type 1
( see spinocerebellar ataxia )
|
| |
spinocerebellar diseases, other
|
| | Spondylo-Epiphyseal Dysplasia
( see musculoskeletal anomalies, other )
|
| |
spondyloarthropathies
|
|
| |
spondylosis, lumbar
|
|
| |
spontaneous abortion
|
|
| | spontaneous cervical artery dissection
( see cervical artery dissection, spontaneous )
|
| |
sporadic inclusion body myositis
|
| | squamous cell carcinoma
( see skin cancer, non-melanoma )
|
| | squamous cell carcinoma of the head
( see skin cancer, non-melanoma )
|
| | squamous cell carcinoma of the head and neck
( see skin cancer, non-melanoma )
|
| | squamous cell carcinoma of the neck
( see skin cancer, non-melanoma )
|
| | stable angina of effort
( see angina of effort, stable )
|
| |
staphylococcal toxins
|
| |
Stargardt disease
|
|
| |
stature
|
| | steatohepatitis
( see liver disease, chronic and cirrhosis )
|
| |
steatohepatitis, non-alcoholic
|
| | steatohepatitis, nonalcoholic
( see liver disease, nonalcoholic fatty )
|
| |
stem cell transplant complications
|
| |
stem cell transplantation complications
|
| | stem cell transplantation outcome
( see bone marrow transplant complications )
|
| |
steroid hormones
|
| |
steroid weaning
|
| |
Still's disease
|
|
| |
stomach cancer
|
|
| |
stratum corneum proteins, glycated
|
| | Streptococcus pneumoniae
( see pneumonia, pneumococcal )
|
| |
stress
|
|
| |
stroke
|
|
| |
stroke, atherothrombotic
|
|
| | stroke, hemorrhagic
( see hemorrhage, intracranial )
|
| | stroke, ischemic
( see cerebrovascular disease, ischemic )
|
| |
stroke, lacunar
|
|
| |
styrene toxicity
|
| |
subarachnoid hemorrhage
|
|
| |
subconjunctival hemorrhage
|
| | subfertility
( see infertility, male )
|
| |
substance abuse
|
|
| |
substance dependence
|
|
| | substance dependence, antisocial
( see substance dependence )
|
| |
substrate activity
|
| | sudden cardiac death
( see cardiac death )
|
| | sudden infant death
( see SIDS/sudden infant death syndrome )
|
| | sudden infant death syndrome (SIDS)
( see SIDS/sudden infant death syndrome )
|
| | suicidal behavior
( see mental disorder )
|
| | suicidal ideation
( see mental disorder )
|
| |
suicide
|
|
| | suicide due to depression
( see suicide )
|
| | suicide, alcohol-dependent
( see suicide )
|
| | sulfasalazine, adverse effects of
( see sulfonamides, adverse effects of )
|
| |
sulfonamide toxicity
|
| |
sulfonamides, adverse effects of
|
| |
sulfone metabolism
|
| | sulphamethoxazole hypersensitivity
( see sulfonamide toxicity )
|
| | sun burn
( see sunburn )
|
| |
sunburn
|
|
| |
sweat chloride
|
| | sympathetic ophthalmia
( see ophthalmia, sympathetic )
|
| | synthetic hemodialysis graft failure
( see hemodialysis graft failure )
|
| |
systematic inflammatory response syndrome
|
| |
systemic inflammatory hyporesponsiveness
|
| |
systemic inflammatory response syndrome
|
| | systemic lupus erythematosus
( see lupus erythematosus )
|
| | systemic sclerosis
( see sclerosis, systemic )
|
| |
systolic blood pressure
|
| |
| | T | Top |
| |
tachycardia, ventricular
|
|
| |
tacrolimus pharmacokinetics
|
| |
TAFI activity
|
| |
Takayasu's arteritis
|
|
| |
tamoxifen, metabolism
|
| | tamoxifen, prophylactic effect of
( see breast cancer )
|
| | Tangier Disease
( see lipoprotein deficiencies )
|
| |
tardive dyskinesia
|
|
| |
Tay-Sachs disease
|
|
| |
temperament
|
| |
tempomandibular joint erosion
|
| |
tenoxicam concentrations
|
| |
testicular atrophy
|
| | testicular atrophy, alcohol-induced
( see testicular atrophy )
|
| |
testicular cancer
|
|
| |
testicular dysfunction, other
|
| | testis, maldescent of the
( see undescended testis )
|
| |
testosterone
|
| | tetrahydrobiopterin (BH4) deficiency
( see amino acid disorder )
|
| |
TGF-beta1
|
| | thalasemia, alpha
( see thalassemia )
|
| |
thalassemia
|
|
| | thalassemia, alpha
( see thalassemia )
|
| | thalassemia, beta
( see thalassemia )
|
| |
thalidomide metabolites
|
| | thanatophoric dysplasia
( see dwarfism )
|
| | Thiamine-Responsive Megaloblastic Anemia Syndrome
( see anemia, megaloblastic, other )
|
| |
thiopurine
|
| |
thiopurine methyltransferase activity
|
| |
thiopurine methyltransferase phenotype
|
| |
thiopurine S-methyltransferase phenotype
|
| |
thiopurine S-methytransferase activity
|
| |
thioridazine plasma levels
|
| | thrombangiitis obliterans
( see Buerger's disease )
|
| |
Thrombin activatable fibrinolysis inhibitor
|
| |
thrombin-activatable fibrinolysis inhibitor antigen
|
| |
thrombin-antithrombin complex
|
| | thrombocythemia
( see lymphoproliferative disorders )
|
| | thrombocythemia, non-familial essential
( see lymphoproliferative disorders )
|
| | thrombocytopenia
( see thrombocytopenia, other )
|
| |
thrombocytopenia, other
|
| |
thrombocytopenic purpura, idiopathic
|
|
| |
thrombocytosis
|
| | thromboembolic complications, subsequent venous
( see thromboembolism, venous )
|
| | thromboembolic events, postoperative
( see thromboembolism, postoperative )
|
| | thromboembolism
( see thromboembolism, venous )
|
| | thromboembolism, arterial
( see atherothrombosis )
|
| |
thromboembolism, postoperative
|
|
| | thromboembolism, pulmonary
( see pulmonary thromboembolism )
|
| |
thromboembolism, venous
|
|
| | thrombophilia
( see thromboembolism, venous )
|
| | thrombophilia, severe inherited
( see thromboembolism, venous )
|
| | thrombophilia, venous
( see thromboembolism, venous )
|
| |
thromboplastin time, activated partial
|
| | thrombosis
( see thromboembolism, venous )
|
| | thrombosis, arterial
( see arterial thrombosis )
|
| | thrombosis, cerebral venous
( see cerebral venous thrombosis )
|
| |
thrombosis, deep vein
|
|
| |
thrombosis, vascular access
|
| | thrombosis, venous
( see thromboembolism, venous )
|
| | thrombotic complications
( see thromboembolism, venous )
|
| | thrombus formation, arterial
( see arterial thrombosis )
|
| |
thrombus, atrial
|
| | thrombus, left ventricular
( see myocardial infarct )
|
| | thryoid cancer
( see thyroid cancer )
|
| |
thryoiditis, chronic lymphocytic
|
| |
thryoiditis, subacute granulomatous
|
|
| |
thryotoxic periodic paralysis
|
| | thyroid agenesis
( see hypothyroidism, congenital )
|
| |
thyroid autoimmunity
|
| |
thyroid cancer
|
|
| | thyroid carcinoma, sporadic medullary
( see thyroid cancer )
|
| |
thyroid disease
|
| | thyroid disease, autoimmune
( see thyroiditis, chronic lymphocytic )
|
| | thyroid dysgenesis
( see hypothyroidism, congenital )
|
| |
thyroid function
|
| |
thyroiditis, chronic lymphocytic
|
|
|
| | thyroiditis, Hashimoto
( see thyroiditis, chronic lymphocytic )
|
| | thyroiditis, Hashimoto's
( see thyroiditis, chronic lymphocytic )
|
| |
thyrotoxic periodic paralysis
|
| |
TIMP-1
|
| |
Tissue type plasminogen activator-regulated secretion
|
| |
tissue-type plasminogen activator
|
| |
tissue-type plasminogen activator levels
|
| |
TNF-alpha
|
| |
TNF-alpha plasma levels
|
| | tobacco dependence
( see tobacco use disorder )
|
| |
tobacco use disorder
|
|
| |
tooth loss
|
|
| | Torsion Dystonia
( see dystonia, torsion )
|
| |
Tourette syndrome
|
|
| |
toxic shock syndrome
|
| |
toxoplasmosis
|
|
| |
tramadol metabolism
|
| |
tramadol pharmacokinetics
|
| |
tranferrin
|
| |
trans, trans-muconic acid excretion, rate of
|
| |
trans-fat, response to
|
| |
transferrin saturation
|
| |
transient myeloproliferative disorder
|
| |
trauma
|
| |
trauma complications
|
| |
trazodone levels
|
| |
Treacher Collins
|
| |
treatment with fluvastatin, response to
|
| |
triacylglycerol
|
| |
triacylglycerols
|
| |
tricho-dento-osseous syndrome
|
| |
triglyceral
|
| |
triglyceride
|
| |
triglycerides
|
| |
trimipramine pharmakokinetics
|
| | trisomy 21
( see Down's syndrome )
|
| | Trypanosoma cruzi infection
( see Chagas' disease )
|
| |
tubal pathology
|
| |
tuberculosis
|
|
| |
tuberous sclerosis
|
|
| | Tuberous sclerosis complex
( see tuberous sclerosis )
|
| |
tumor markers
|
| |
tumor necrosis factor (TNF) production
|
| |
tumor necrosis factor bioactivity
|
| | Turner Syndrome
( see gonadal dysgenesis )
|
| | type 1 diabetes
( see diabetes, type 1 )
|
| |
typhoid fever
|
|
| | tyrosinemia
( see aromatic amino acid disturbances )
|
| |
| | U | Top |
| | ulcer, duodenal
( see duodenal ulcer )
|
| | ulcer, gastric
( see gastric ulcer )
|
| | ulcer, peptic
( see peptic ulcer )
|
| | ulcer, post-thrombotic leg
( see varicose ulcers )
|
| | ulcer, venous
( see varicose ulcers )
|
| |
ulcerative colitis
|
|
| | ulcers
( see duodenal ulcer )
|
| | ulcers, venous leg
( see varicose ulcers )
|
| |
ultrarapid drug metabolism
|
| |
undescended testis
|
| | unipolar affective disorder
( see affective psychoses )
|
| | unipolar depression
( see depression )
|
| | unipolar disorder
( see affective psychoses )
|
| | upper aerodigestive tract cancer
( see cancers of the lip, oral cavity, and pharynx )
|
| |
urea
|
| | Ureaplasma urealyticum infection
( see mycoplasma infections )
|
| |
uremia
|
|
| |
uric acid
|
| | uricemia
( see hyperglycemia )
|
| |
urinary calculus
|
|
| | urinary infection
( see urinary tract infection )
|
| |
urinary mutagenicity
|
| |
urinary system anomalies
|
| |
urinary tract infection
|
| |
urogenital disorders
|
| | urolithiasis
( see urinary calculus )
|
| | urothelial cancer
( see bladder cancer )
|
| | urothelial carcinoma
( see bladder cancer )
|
| |
urothelial cell exfoliation, cytopathological changes in
|
|
| |
urticaria
|
| |
Usher syndrome
|
| |
Usher Syndrome Type 1
|
| | Usher Syndrome Type II
( see retinitis pigmentosa )
|
| |
uterine cancer
|
|
| |
uterine fibroids
|
|
| | uterine leiomyomas
( see uterine fibroids )
|
| |
UV, sensitivity to
|
| | UVB-induced immunomodulation
( see immunological findings & UVB )
|
| | uveal melanoma
( see eye cancer )
|
| |
uveitis
|
| |
| | V | Top |
| |
vacuolar myelopathy
|
| |
vaginal micro-flora
|
| | valve damage in rheumatic fever
( see rheumatic heart disease )
|
| | van Buchem disease
( see hyperostosis of skull )
|
| |
varicose ulcers
|
|
| |
varicose veins
|
|
| | vas deferens, absence of
( see absence of vas deferens, congenital )
|
| | vascular dementia
( see dementia, arteriosclerotic )
|
| |
vascular disease
|
|
| | vascular disease, cardiac allograft
( see vascular disease )
|
| |
vascular endothelial growth factor
|
| |
vascular function
|
| |
vascular injury, malignant
|
|
| | vascular morbidity
( see vascular disease )
|
| |
vascular morphology
|
| |
vascular NAD(P)H oxidase activity
|
| |
vascular reactivity
|
| |
vascular response
|
| | vasculitis
( see arteritis )
|
| | vasculitis, antineutrophil cytoplasmic antibodies-associated small vessel
( see arteritis )
|
| |
vasoconstriction
|
| |
vasoconstriction, coronary
|
| | vasodilation
( see peripheral vascular disease )
|
| |
vasodilation during pregnancy
|
|
| | vasospastic angina
( see angina, vasospastic )
|
| | vein occlusion, central renal
( see occlusion, renal vein, central )
|
| | vein occlusion, hepatic
( see Budd-Chiari syndrome )
|
| |
venous insufficiency, chronic
|
| | venous thromboembolism
( see thromboembolism, venous )
|
| | venous thrombosis
( see thromboembolism, venous )
|
| | ventricular arrhythmia, malignant
( see arrhythmia, ventricular malignant )
|
| |
ventricular assist devices complications
|
| |
verbal fluency
|
| |
vesicoureteral reflux
|
|
| |
vincristine pharmacokinetics
|
| |
vinyl choride toxicity
|
|
| |
violent behavior
|
| |
visual disorder
|
|
| |
vitamin B12
|
| |
vitamin B6
|
| |
vitiligo
|
|
| |
Vogt-Koyanagi-Harada syndrome
|
|
| |
vomiting
|
| | Von Hippel-Lindau Syndrome
( see hamartomas )
|
| | von Recklinghausen disease
( see neurofibromatosis1 )
|
| | von Willebrand Disease
( see von Willebrand's Disease )
|
| |
von Willebrand factor
|
| |
von Willebrand's Disease
|
|
| |
vulvar cancer
|
| |
vulvar vestibulitis syndrome
|
|
| |
| | W | Top |
| | Waardenburg Syndrome
( see aromatic amino acid disturbances )
|
| |
waist circumference
|
| | warfarin sensitivity
( see anticoagulant complications )
|
| |
warfarin therapy, response to
|
| |
warts
|
| |
Wegener's granulomatosis
|
|
| |
weight
|
| |
weight gain
|
|
| | weight gain, antipsychotic drug-induced
( see schizophrenic disorders )
|
| |
weight loss
|
| | Werner Syndrome
( see endocrine disorders, other )
|
| | Werner's syndrome
( see endocrine disorders, other )
|
| |
Wernicke-Korsakoff syndrome
|
|
| |
white blood cell count
|
| |
white matter disease
|
|
| | Williams syndrome
( see congenital malformation syndromes, other )
|
| |
Wilm's tumor
|
| | Wilson disease
( see Wilson`s disease )
|
| | Wilson disease, fine motor symptoms in
( see Wilson`s disease )
|
| |
Wilson`s disease
|
| | Wilsons disease
( see Wilson`s disease )
|
| | Wolf-Hirschhorn Syndrome
( see Autosomal deletion syndromes )
|
| |
| | X | Top |
| | X-linked adrenal hypoplasia congenita
( see adrenal anomalies, congenital )
|
| | X-Linked Adrenoleukodystrophy
( see Addison's disease )
|
| | X-linked lymphoproliferative disease
( see lymphoproliferative disorders )
|
| | x-linked mental retardation
( see congenital anomaly )
|
| | X-Linked Myotubular Myopathy
( see Nemaline body disease )
|
| |
X-linked ocular albinism
|
| | X-Linked Periventricular Heterotopia
( see Holoprosencephaly )
|
| | X-linked severe combined immunodeficiency
( see immunity deficiency, combined )
|
| | X-linked spondyloepiphyseal dysplasia tarda
( see musculoskeletal anomalies, other )
|
| |
| | Z | Top |
| | Zellweger Syndrome
( see congenital malformation syndromes, other )
|
| |
zinc
|
